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Abstract
Glycerol production in Plasmodium falciparum:
Towards a detailed kinetic model
W.W. Adams
Department of Biochemistry
University of Stellenbosch
Private Bag X1, Matieland, 7602, South Africa
Thesis: MSc (Biochemistry)
January 2015
Having caused the deaths of more than 10 million individuals since 2000 with
most of them occurring in Africa, malaria remains a serious disease that re-
quires undivided attention. To this end a detailed kinetic model of Plasmodium
falciparum glycolysis was constructed, validated and used to determine po-
tential drug targets for the development of novel, effective antimalarial therapies.
The kinetic model described the behaviour of the glycolytic enzymes with
a set of ordinary differential equations that was solved to obtain the steady
state fluxes and concentrations of internal metabolites. The model included a
glycerol branch represented in a single fitted equation. This present study set
out to detect, characterise, and incorporate into the model the enzymes that
constitute the glycerol branch of P. falciparum glycolysis.
The kinetic parameters of glycerol 3-phosphate dehydrogenase (G3PDH), the
first enzyme in the branch and catalyst of the dihydroxyacetone phosphosate
(DHAP) reducing reaction, was determined and added to the detailed kinetic
ii
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model. The model was subsequently validated by comparing its prediction of
steady state fluxes with experimentally measured fluxes.
Once it was evident that the predictions of the unfitted model agreed with
experimentally measured fluxes, metabolic control analysis was performed on
this branched system to ascertain the distribution of control over the steady
state flux through the glycerol branch. The control G3PDH exercised over its
own flux was less than expected due to the enzyme’s sensitivity to changes in
NADH and thus the redox balance of the cell.
Attempts were made to detect the enzymes responsible for the conversion
of glycerol 3-phosphate (G3P) to glycerol. Very low levels of glycerol kinase
activity was observed. Although G3P-dependent release of inorganic phosphate
was detected results were inconclusive as to whether a non-specific phosphatase
also mediated the conversion.
Overall, the expansion of the model to include G3PDH did not affect the
steady state metabolite concentrations and flux adversely.
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Uittreksel
Gliserol produksie in Plasmodium falciparum:
Ontwikkeling van ’n uitvoerige kinetiese model
W.W. Adams
Departement Biochemie
Universiteit van Stellenbosch
Privaatsak X1, Matieland 7602, Suid Afrika
Tesis: MSc (Biochemie)
Januarie 2015
Vanaf die jaar 2000 het malaria die dood van meer as 10 miljoen mense veroor-
saak. Die meeste sterftes het in Afrika voorgekom —’n aanduiding van hoe
ernstige siekte dit is en een wat onverdeelde aandag moet geniet. Om hierdie
rede is ’n gedetaileerde kinetiese model van glikoliese in Plasmodium falcipa-
rum gebou, gevalideer en gebruik om potensiële dwelm teikens te identifiseer
vir die ontwikkeling van nuwe, meer effektiewe anti-malaria terapieë.
Die kinetiese model beskryf die gedrag van die glikolitiese ensieme in terme
van gewone differensiële vergelykings wat opgelos is om die bestendige toe-
stand fluksies en interne metaboliet konsentrasies te bepaal. Die model sluit
’n gliserol-tak in wat deur ’n enkele aangepaste vergelyking verteenwoordig
word. Hierdie studie het voorgeneem om die ensieme van die gliserol-tak van P.
falciparum glikoliese te identifiseer, karakteriseer en in die model te inkorporeer.
Ons het die kinetiese parameters van die eerste ensiem in die gliserol-tak,
gliserol 3-fosfaat dehidrogenase (G3PDH), die katalis van die dihidroksiasetoon
iv
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fosfaat(DHAP) reduserende reaksie, bepaal. Die kinetiese parameters is by
die gedetaileerde model gevoeg. Validering het plaasgevind deur die model se
voorspellings met eksperimenteel bepaalde waardes te vergelyk.
Toe dit duidelik geword het dat die voorspellings van die model met die
eksperimenteel bepaalde fluks ooreenstem, is metaboliese kontrole analiese op
die vertakte sisteem uitgevoer. Dit is gedoen om vas te stel hoe die bestendige
toestand fluks deur die gliserol-tak beheer word. G3PDH het nie volle beheer
oor sy eie fluks nie, in teenstelling met ons vergewagtinge.
Daar is gepoog om vas te stel watter ensieme verantwoordelik is vir die produk-
sie van gliserol vanuit gliserol 3-fosfaat (G3P). ’n Lae gliserolkinase aktiwiteit
is waargeneem. Alhoewel G3P afhanklike vrystelling van anorganise fosfaat
waargeneem is, is dit nie duidelik vanuit die resultate of die proses deur ’n
nie-spesifieke fosfatase uitgevoer word nie.
Die uitbreiding van die model om ’n G3PDH vergelyking in te sluit het nie die
bestendige toestand metaboliet konsentrasies en fluks negatief geaffekteer nie.
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Prelude
Having caused the deaths of more than 10 million individuals since 2000 with
most of them occurring in Africa, malaria remains a serious disease that requires
undivided attention1. The World Health Organization (WHO), in its World
Malaria Report 2013 1, reported a decline in malaria incidence and mortality
rates worldwide in all age groups since 2000. Despite best efforts to control and
eradicate the disease, drug resistance among the Plasmodium parasites is grow-
ing. Among the five Plasmodium species that infect humans, P. falciparum is
the most lethal.
In an effort to aid the drug discovery process, Penkler2 constructed a detailed
kinetic model of the Emden-Meyerhof-Parnas (glycolysis) pathway of P. falci-
parum D10. Construction of the model (Penkler 1 model), which is available
on JWS Online (http://jjj.biochem.sun.ac.za), followed a bottom up approach
that required the measurement of the kinetic parameters of each enzyme in the
pathway. The ATPase and glycerol dehydrogenase (GlrDH) reactions were the
only two reactions that were fitted, the others were determined experimentally.
Metabolic control analysis3,4,5, parameter sensitivity analysis2 and the differen-
tial control approach6,7 were used to validate the model by determining which
enzymes exerted the highest control over the steady state flux and metabolite
concentrations, and testing whether an inhibitor of one of these pathogen
enzymes could inhibit the flux with little adverse effects on the host system.
Cytochalasin B was the inhibitor and the P. falciparum hexose transporter 1
(PfHT1) was the chosen enzyme. The model described the behaviour of the
system well, thereby passing the validation tests.
However, the glycerol branch of the Penkler model was represented by a single
fitted rate equation that was based on KM values from the scientific literature.
The Vmax value for the glycerol branch was fitted to match the steady state
1
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flux through the branch. This present work aimed to elucidate the kinetic
behaviour of the glycerol branch by:
• biochemically characterising glycerol 3-phosphate (G3P) dehydrogenase,
• detecting and kinetically characterising glycerol kinase,
• identifying and characterising any G3P-dependent phosphatase activity
• replacing the single fitted rate equation that represents the glycerol branch
in the original model with the kinetic information obtained in this study
• determining the factors involved in the flux control of the glycerol branch.
The results of this study are presented in Chapter 3 along with a discussion of
the results in the context of the background information presented in Chapter
1. The materials and methods used to conduct the experiments are explained in
Chapter 2. This thesis is concluded by a general discussion on the limitations
and future research based on this study in Chapter 4.
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Chapter 1
Background
This chapter contains an overview of the malarial threat, life cycle of the
parasite, glycolysis and the enzymes involved in production and consumption
of glycerol and its activated form (i.e. glycerol-3-phosphate) as well as the
fundamentals of kinetic modeling.
1.1 Introduction
Malaria, a disease caused by parasites of the genus Plasmodium, has plagued the
human race for millenia8. Of the five Plasmodium species that infect humans,
P. falciparum and P. vivax are the most prevalent and P. falciparum the most
lethal1.
According to the WHO1, P. falciparum mainly affects Africa while P. vivax
enjoys a wider distribution range due to its ability to grow at lower temperatures
and higher altitudes. It is estimated that 627 000 people died from the disease
in 2012 while there were over 200 million new cases worldwide. Africa was the
worst affected region with 165 million new cases and 562 000 deaths in 2012.
South-East Asia, the second worst affected region, experienced 27 million new
cases and 42 000 deaths.
1.2 Plasmodium falciparum life cycle
As reviewed by others9,8and references therein, the P. falciparum life cycle in humans
begins when a female Anopheles mosquito takes a blood meal. Sporozoites
residing in the salivary glands of the Plasmodium infected mosquito are de-
posited in the skin from where they haphazardly make their way to blood
vessels where they are transported by the blood stream to the liver10. In the
3
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liver the sporozoites infect hepatocytes and mature into schizonts undergoing a
substantial amount of nuclear divisions and cytokinesis in the process. After
subsequent rupture of the liver cell, thousands of merozoites are released into
the blood stream where they subsequently invade erythrocytes. Some P. vivax
parasites continue to reside in the liver in a dormant hypnozoite form8.
The intra-erythrocytic asexual phase of the Plasmodium life cycle marks the
onset of clinical symptoms. Once inside erythrocytes, merozoites develop into
trophozoites. During the early trophozoite stage the parasite has a ring-like
appearance, the centre of which fills up as the trophozoite matures. During
the next 48 hours, the trophozoites mature into schizonts which give rise to up
to 32 merozoites, and rupture releasing merozoites into the blood stream once
again where they infect new erythrocytes.
Some merozoites develop into male and female gametocytes which remain
dormant until they are taken up by an Anopheles mosquito during a blood
meal11. Fertilisation ensues in the mosquito’s gut once gametes are formed.
The diploid zygote undergoes meiosis producing motile ookinetes that penetrate
the midgut and form oocysts which give rise to sporozoites. These migrate to
the mosquito’s salivary glands, completing the life cycle.
1.3 Parasite energy supply
In addition to the onset of clinical symptoms, the intra-erythrocytic or asexual
phase of the P. falciparum life cycle is characterised by a 100-fold increase in
glucose consumption in the infected erythrocyte12. Glucose is the trophozoite’s
main source of free energy13.
Although P. falciparum possesses a functional electron transport chain (ETC)
located in the mitochondrion, the ATP synthase (Complex V) of the ETC
does not generate ATP (unlike mammalian ATP synthase) and functions as a
proton pump14,15,16,13. The ETC has therefore been proposed to act as an elec-
tron sink17 accepting reducing equivalents from its five dehydrogenases18, viz.
NADH:ubiquinone oxidoreductase (PfNDH2), succinate:ubiquinone oxidore-
ductase (Complex II or SDH), glycerol-3-phosphate dehydrogenase (G3PDH),
malate quinone oxidoreductase (MQO) and dihydroorotate dehydrogenase
(DHODH). Of these, MQO and PfNDH2 have been identified as drug targets
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due to their absence in human mitochondria while the unique molecular differ-
ences in DHODH distinguishes it from its human homologue18. Despite its lack
of contribution to P. falciparum energy metabolism, the ETC is essential for
the parasite’s existence since viable deletion mutants could not be obtained19.
1.4 Glycolysis
Glycerol (Glr) is produced2 (Fig. 1.1) when P. falciparum hexose transporter
1 (PfHT1) traffics glucose into the parasite cytosol where it is sequentially
converted by hexokinase (HK), phosphoglucose isomerase (PGI), phospho-
fructokinase (PFK) and aldolase (ALD) to glyceraldehyde (GAP) and dihy-
droxyacetone phosphate (DHAP). Triose phosphate isomerase (TPI) converts
DHAP to GAP while NAD+-dependent glycerol-3-phosphate dehydrogenase
(G3PDH) catalyses the reduction of DHAP to glycerol-3-phosphate (G3P) with
the concomitant oxidation of NADH. G3P is subsequently dephosphorylated by
glycerol kinase (GK) working in reverse or a non-specific phosphatase and the
Glr exported via P. falciparum aquaglyceroporin (PfAQP)20,21. It is believed
that maintenance of the redox balance of the cell is the main driving force
behind G3P and glycerol production22,2,23.
Glycolysis2 continues as GAP dehydrogenase (GAPDH), phosphoglycerate
kinase (PGK), phosphoglycerate mutase (PGM), enolase, pyruvate kinase (PK)
and lactate dehydrogenase (LDH) convert GAP to lactate which is transported
out of the parasite via a proton-coupled lactate transporter24. This transporter
also transports pyruvate24,25.
Although most of the glycolytic flux produces lactate, small but significant
amounts feed the pentose phosphate pathway as well as the glycerol and carbon
dioxide fixation branches2 .
1.5 Enzymes of the glycerol branch
A closer look will now be taken at the enzymes of the glycerol branch.
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Figure 1.1: Overview of the currently accepted scheme of glycerol metabolism
in asexual Plasmodium falciparum. The parasite’s classic glycolytic pathway
processes glucose to lactate, pyruvate and glycerol as well as G3P which is
used in lipid metabolism. The red circles indicate enzymes whose genes and
activities have been identified while the white circles with a question mark in
their centre (accompanied by finely dashed arrows) show enzymes whose genes
and activities have not been observed yet in P. falciparum. Blue circles mark
enzymes whose activities have not been detected but whose genes have been
identified. Dashed arrows indicate multi-enzyme pathways. Enzyme names are in
italics while metabolites and co-factors are bold faced. AGPAT, 1-acyl-glycerol-3-
phosphate acyltransferase; CDS, CDP-DAG synthase; CLS, cardiolipin synthase;
DGAT, acyl-CoA:diacylglycerol acyltransferase; ENO, enolase; GlcTr, glucose
transporter; GPAT, glycerol-3-phosphate acyltransferase; PAP-2, phosphatidic
acid phosphatase type 2.
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1.5.1 Glycerol 3-phosphate dehydrogenase
As stated before and shown in Figure 1.1, P. falciparum G3PDH (EC 1.1.1.8)
catalyses the conversion of DHAP to G3P while simultaneously oxidising NADH
to NAD+ 26. P. falciparum G3PDH is not a well-characterised enzyme. How-
ever, there is a lot of literature on the biochemical and structural properties
of the enzyme in yeast27,28,29,30,31, Trypanosoma spp. and Leishmania mexi-
cana 26,32,33,34, and mammalian species35,36,37,38,39,40,41,42. Transcription of the
two putative P. falciparum G3PDH genes (PlasmoDB identifier1 PF11_0157
and PFL0780w) peak at 37 and 19 hours, respectively44. The molecular mass
of the dimeric enzyme, as recorded in the scientific literature45,34,46,26, ranges
from 65-80 kDa for a variety of organisms. The crystal structure of Leishmania
mexicana G3PDH was determined at 1.75 Å and at 1.9 Å with G3PDH bound
to DHAP and NADH26,34. Michaelis constants (KM) of G3PDH for DHAP,
NADH, G3P and NAD+ are about 0.22 mM, 0.014 mM, 1.3 mM, and 0.35 mM,
respectively27,26,28,32,30.
The exact mechanism by which G3P dephosphorylation occurs is unknown22,13
as there are conflicting reports regarding P. falciparum glycerol kinase activity
in the asexual blood stage47,48 and no G3P specific phosphatase genes have
been detected in the genome as yet13.
1.5.2 Glycerol kinase
Schnick et al. 48 determined the mRNA expression levels of glycerol kinase
(GK; EC 2.7.1.30; PlasmoDB identifier: PF13_0269) at various stages of P.
falciparum development. GK was only expressed in the sexual stages of the life
cycle, not in the asexual erythrocyte stage. They also determined the crystal
structure of the dimeric 501 amino acid residue enzyme at 1.5 Å. The enzyme
catalyses the phosphorylation of glycerol by ATP producing G3P and ADP. For
a recombinant construct of the enzyme expressed in Escherichia coli, Schnick
et al. determined that the KM values of GK for glycerol and ATP were 18 ±
2 µM and 21 ± 1 µM and Vmax values of 15.5 ± 0.4 U mg protein−1 and 18.3
± 0.35 U mg protein−1, respectively. The authors also found that GK was not
inhibited by fructose-1,6-bisphosphate. The reverse reaction of the enzyme was
not studied.
1PlasmoDB is a functional genomic database for all Plasmodium spp. created by
Aurrecoechea et al. 43 .
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Although Naidoo and Coetzer 47 could not detect P. falciparum GK activ-
ity in the blood stage either, their GK knock-out strain (3D7∆PfGK ) grew
43.4% slower than the wild type strain. Only 30% of synchronous ring stage
3D7∆PfGK parasites fully matured to late trophozoites/schizonts after 120
hours incubation. The rest of the parasites were still in the ring stage. The
GK deletion mutants formed less merozoites compared to wild type. Further-
more, when incubated with 14C-glycerol, relative to the wild type strain, the
3D7∆PfGK strain only incorporated 48.4 ± 10.8% and 53.1 ± 5.7% of the radio-
labelled glycerol into phosphatidylcholine (PC) and phosphatidylethanolamine
(PE), respectively. The authors could not detect any other glycerol phosphoryla-
tion mechanism to account for the radiolabelled glycerol that was incorporated
into these phospholipids (PLs). In a previous study, the group determined that
PfGK shared 50% identity with E. coli GK49.
1.5.3 Non-specific phosphatase
Hills et al. 50 investigated a type 2 phosphoglycerate mutase from P. falci-
parum (PfPGM2; PlasmoDB identifier: PFD0660w) comparing its crystal
structure and kinetic behaviour to those of Cryptosporidium parvum glycolytic
dPGM. (The "d" in dPGM indicates that the enzyme is dependent on a 2,3-
bisphosphoglycerate co-factor for catalytic activity. Enzymes belonging to the
phosphoglycerate mutase family that do not depend on 2,3-bisphosphoglycerate
for catalytic activity are designated independent PGMs or iPGMs.) Their
study showed that PfPGM2 is an iPGM readily dephosphorylating fructose
6-phosphate (F6P), fructose-1,6-bisphosphate (F1,6BP) and triose phosphates,
such as 3-phosphosglycerate (3PG), 2,3-bisphosphoglycerate (2,3-BPG) and
phosphoenolpyruvate (PEP). The amino acid sequence and crystal structure
of PfPGM2 also differed from that of C. parvum, a related Apicomplexan. It
is possible that PfPGM2 dephosphorylates G3P to produce glycerol which is
subsequently exported out of the cell.
1.5.4 Aquaglyceroporin
Export and import of glycerol to and from the parasitophorous vacuole medium
occurs via an aquaglyceroporin unique to Plasmodium species. An essential pro-
tein of P. falciparum metabolism, the P. falciparum aquaglyceroporin (PfAQP;
PlasmoDB identifier: PF11_0338) plays an important role in osmoregulation
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and the influx and eﬄux of uncharged molecules of low molecular weight such
glycerol, water, ammonia, urea, and four- and five-carbon sugar alcohols20.
The 258 amino acid PfAQP, a member of the major intrinsic protein (MIP)
family, is a water and a solute channel which has high affinity for both water
and glycerol20,21. The homotetrameric nature of PfAQP has not been confirmed
to date even though it was modeled as such by Beitz and co-workers21,51. The
21 kDa water-glycerol channel is highly similar to, although slightly shorter
in length than, E. coli glycerol facilitator (GlpF) having 50% similar and 35%
identical amino acid residues20.
Beitz’s group51 expressed PfAQP in E. coli by substituting the A-T rich gene
with an E. coli expressible one while keeping the amino acid sequence constant to
obtain a crystal structure. Six transmembrane helices span the parasite plasma
membrane while loops B and E each contain half-helices that form the seventh
transmembrane helix. These anti-parallel half-helices contain the canonical
Asn-Pro-Ala (NPA)-motif typical of aquaporins and aquaglyceroporins. The
NPA-motifs in loops B and E are slightly modified to Asn-Leu-Ala and Asn-
Pro-Ser, respectively. The asparagines (Asn70 and Asn193) reorient water
molecules leading to the disruption of the hydrogen bonds in a file of water21.
In so doing, the asparagines prevent protons from using the file of water as a
proton wire and ions from traversing the pore. Trp124, Glu125 and Thr126 (the
WET triad) located on Loop C which dips into the extracellular vestibule of the
pore interact with Arg196 to regulate water permeability21,51. The 25Å long
pore is 3.0Å wide at its narrowest section51.
1.6 Use in lipid metabolism
The study conducted by Naidoo and Coetzer 47 showed that P. falciparum can
take up, phosphorylate and use extracellular glycerol since 14C-glycerol was
incorporated into phosphatidylcholine (PC) and phosphatidylethanolamine
(PE). These two phospholipids (PLs) along with phosphatidylinositol (PI) are
the main constituents of the P. falciparum plasma membrane52,53 comprising
40-50%, 35-45% and 4-11%, respectively. The infected erythrocyte membrane
experiences a 6, 8 and 14 fold increase in PC, PE, and PI concentrations,
respectively17. Phosphatidylserine (PS), neutral lipids (i.e. di- and triacylglyc-
erides), cardiolipin (CL) and sphingomyelin make up the rest of the erythrocyte
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membrane17,52.
Glycerophospholipid and acylglycerol synthesis have been extensively reviewed
elsewhere17,54. They have also been summarised in Figure 1.1. Briefly, glycerol-
3-phosphate acyltransferase (GPAT; PlasmoDB identifier: PFL0620c) acy-
lates G3P and acyl-coenzyme A to produce lysophosphatidic acid (lysoPA)55.
Through the action of 1-acyl-glycerol-3-phosphate acyltransferase (AGPAT)
(PfPlsC, PlasmoDB identifier: PF14_0421) phosphatidic acid (PA) is formed.
PA is incorporated into the structures of PC and PE by the enzymes of the
P. falciparum Kennedy pathways and into PI and PS through their formation
pathways56,57,58,59,60,61.
Diacylglycerol (DAG) formation follows the dephosphorylation of PA by PA
phosphatases, PAP-1 (Mg2+-dependent) and PAP-2 (Mg2+-independent)17.
CDP-DAG synthase can also activate DAG to CDP-DAG to have it participate
in the Kennedy pathways17,58.
Triacylglycerol (TAG) is formed once acyl-CoA:DAG acyltransferase (DGAT;
PlasmoDB identifier: PF3D7_ 0322300) acylates DAG54. Palacpac et al.54
observed a marked increase in TAG production during the late trophozoite,
schizont and segmented schizont stages of parasite development. They hypoth-
esized that TAG and the other constituents of lipid bodies might play a key
role in schizont rupture and merozoite release.
These enzyme catalysed reactions can be represented by rate equations in a
kinetic model. This has been done for phospholipid synthesis in Plasmodium
knowlesi 62 and glycolysis in P. falciparum 2. A brief explanation of the basic
principles of enzyme kinetic modeling follows.
1.7 Principles of kinetic modeling
The principles described below were previously described by Bisswanger 63,
Segel 64 and Cornish-Bowden 65 . Consider the metabolic pathway below (Eq.
1.7.1) where enzymes E1 to E3 convert external metabolite X0 to external
metabolite X3. S1 and S2 are internal metabolites. The enzymes follow
reversible Michaelis-Menten kinetics66,65,64 where each enzyme has the ability
to reversibly convert its substrate into product.
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X0 
E1
S1 
E2
S2 
E3
X3 (1.7.1)
X0 serves as the source of substrate for the pathway while X3 is the sink into
which the metabolites flow. Both external metabolites are parameters of the
system while the internal metabolites are free variables. The system is said to
be open due to the constant influx of substrate X0 and eﬄux of product X3
keeping these external metabolites that are treated as parameters in the model
at a constant concentration and allows the pathway to reach a steady state.
At steady state, metabolite concentrations do not change with time, i.e. their
production and consumption rates are exactly balanced. However, the individual
enzyme rates are not zero as metabolites are still produced and consumed.
It is only under equilibrium conditions that the rate of an enzyme-catalysed
reaction would be zero65. Rate equations describing the kinetic behaviour of
the enzymes in the system can be written as follows:
v1 =
Vf1
x0
Kx0
(
1− s1
x0·Keq
)
1 + x0
Kx0
+ s1
Ks1
(1.7.2)
v2 =
Vf2
s1
Ks1
(
1− s2
s1·Keq
)
1 + s1
Ks1
+ s2
Ks2
(1.7.3)
v3 =
Vf3
s2
Ks2
(
1− x3
s2·Keq
)
1 + s1
Ks1
+ x3
Kx3
(1.7.4)
Vfi (i ∈ {1, 2, 3}) represents the forward maximal velocity (also abbreviated
Vmax in the literature) at which enzyme Ei catalyses the conversion of its
substrate to its product. s1 and s2 denote the concentrations of internal
metabolites S1 and S2. Similarly, x0 and x3 denote the concentrations of
external metabolites X0 and X3. The equilibrium constant Keq indicates
equilibrium conditions. When a reaction is at equilibrium its net rate is zero
and the product to substrate concentration ratio is equivalent to the Keq value.
The Michaelis constants (KM) in Eq. 1.7.2 (i.e. Kx0 and Ks1), for example,
indicate the concentration of said metabolite at which half-maximal velocity is
achieved in the absence of product, i.e. v = 0.5Vf .
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The reversible Michaelis-Menten rate equations may also have the following
form where Vr1 is the maximal velocity of the reverse reaction of enzyme E1:
v1 =
Vf1
x0
Kx0
− Vr1 s1Ks1
1 + x0
Kx0
+ s1
Ks1
The system can be described in terms of a series of ordinary differential equations
(ODEs; see Eq. 1.7.5-1.7.6) that can be numerically integrated to obtain the
concentrations of the internal or variable metabolites. The negative signs in the
ODEs indicate reactions that consume the metabolite while those that produce
the metabolite have positive signs.
ds1
dt
= v1 − v2 (1.7.5)
ds2
dt
= v2 − v3 (1.7.6)
Solving for metabolite concentrations by equating the ODEs to zero yields
steady state concentrations (c) and fluxes (J ). At steady state, the rates of all
the enzymes will be equal and the flux through the system will equal these:
J = v1 = v2 = v3.
These principles apply to all multi-reaction systems, e.g. glycolysis, the pentose
phosphate pathway, the Kennedy pathways, etc.
With a model of the pathway (Eq. 1.7.1) one can determine which enzymes
exert the most control over the steady state flux and concentrations. metabolic
control analysis (MCA), a method developed independently by Kacser and
Burns4 and Heinrich and Rapoport3,5, enables such determinations to be done.
For in-depth reviews and analyses see Fell67 and Hofmeyr68.
The fractional change in a local rate due to a fractional change in a parameter
that interacts with it (e.g. an activator, inhibitor or enzyme concentration)
is defined as the elasticity coefficient. Thus, when enzyme Ei is isolated
from the system and its substrates and products clamped at their steady
state concentrations, a small change in a parameter p (δp) will bring about a
concomitant change in the local rate vi (Eq. 1.7.7).
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 1. BACKGROUND 13
vip =
δ ln vi
δ ln p (1.7.7)
In living systems, enzymes do not operate in isolation. Any change to the local
rate will reverberate throughout the system affecting the steady state flux J
and metabolite concentrations c which are systemic properties. This sensitivity
of a steady state flux to a change in a local rate vi is known as the flux control
coefficient (CJvi ; Eq. 1.7.8). The concentration control coefficient (C
c
vi
) can be
similarly defined (Eq. 1.7.9).
CJvi =
δJ/J
δvi/vi
= δJ
δvi
vi
J
= δ ln J
δ ln vi
(1.7.8)
Ccvi =
δc/c
δvi/vi
= δc
δvi
vi
c
= δ ln c
δ ln vi
(1.7.9)
A control coefficient shows the dependence of a system variable (e.g. J) on an
internal parameter (e.g. enzyme activity) while the response coefficient (RJa )
demonstrates the dependence of a system variable on an external parameter65.
Thus, a fractional change in the concentration of external effector A (δa)
will lead to a fractional change in steady state flux (δJ) or the steady state
concentration of a metabolite (δc):
RJa =
δ ln J
δ ln a & R
c
a =
δ ln c
δ ln a (1.7.10)
External effector A must act on at least one enzyme in the system to produce
a systemic response. Therefore, it will have at least one non-zero elasticity
coefficient:
via =
δ ln vi
δ ln a (1.7.11)
Since a fractional change in the concentration of external effector A will bring
about a fractional change in a local rate vi, this fractional change in vi will
result in a fractional change in the steady state flux (J) such that a flux control
coefficient can be defined (see Eq. 1.7.8). It follows that the flux response
coefficient as a result of the action of external effector A can be mathematically
expressed as the product of elasticity coefficient and flux control coefficient:
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RJa = CJvi
vi
a =
δ ln J
δ ln vi
δ ln vi
δ ln a =
δ ln J
δ ln a (1.7.12)
This same relationship applies to any system variable such as the steady state
concentration of any metabolite.
Armed with this knowledge one can test the validity of these analyses by
inhibiting those enzymes that exert great control over the steady state flux
and metabolite concentrations. Such enzymes in pathogens can also serve as
drug targets especially when their counterparts in the pathogen’s host have
less control over the pathway flux or metabolite concentrations. This rationale
of differential control 6,7 guided Penkler2 in the construction and validation of
a detailed kinetic model on P. falciparum glycolysis.
1.8 Model of P. falciparum glycolysis
Using a bottom up approach69, Penkler measured the initial rates of each
enzyme in P. falciparum glycolysis at various concentrations of substrates,
products and effectors (i.e. activators or inhibitors). Fitting appropriate rate
equations to each enzyme’s data, he obtained KM -values and Vmax-values (in
the forward and reverse reaction directions where possible). These parameters,
along with the initial steady state concentrations of the metabolites, were used
to construct a mathematical model (Penkler1 model available on JWS Online,
http://jjj.biochem.sun.ac.za) using the principles described above to obtain
steady state concentrations of the internal and external metabolites and the
steady state flux through the pathway. The steady state predictions of the
model were partially validated through isolated trophozoite incubations with
labelled and unlabelled glucose.
After the initial validation of the Penkler model further validation was performed
based on MCA analysis which indicated that the glucose transporter (GlcTr),
HK, PFK, GAPDH and the fitted ATPase exercised the greatest control over
the glycolytic flux in P. falciparum. The analysis also revealed that, in addition
to these enzymes, the fitted glycerol dehydrogenase (GlrDH) exerted high
concentration control especially over phospho(enol)pyruvate (PEP) which is an
allosteric modulator of many P. falciparum glycolytic enzymes.
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In applying the differential control approach6,7, Penkler defined the scaled
effectivity which takes the logarithm of the response coefficient a drug elicits in
a pathogen’s host over the logarithm of the response coefficient of a pathogen
due to drug treatment (Eq. 1.8.1).
scaled effectivity =
log
(
|RJ(host)
drug
|
)
log
(
|RJ(pathogen)
drug
|
) = log
(
|CJ(host)vi ·
vi(host)
drug
|
)
log
(
|CJ(pathogen)vi ·
vi(pathogen)
drug
|
) (1.8.1)
Assuming that a drug, such as cytochalasin B, would inhibit an enzyme in
host and parasite to the same degree (i.e. the drug is non-selective; v(host)drug =

v(pathogen)
drug ), the scaled effectivity becomes the ratio of the logarithms of the
flux control coefficients of host and pathogen. Unlike standard effectivity upon
which it is based, scaled effectivity favours reactions with high control in the
parasite and low control in the host.
This property of scaled effectivity is counterintuitive when viewing Eq. 1.8.1
but as our example will show is completely logical. If a reaction has a flux
control coefficient in the host of 0.001 and a flux control coefficient of 0.1 in the
parasite, the logarithms of these flux control coefficients would be -6.9 and -2.3,
respectively. Inserting these values into Eq. 1.8.1 yields a scaled effectivity of
3.0. Conversely, a reaction with high flux control in the host (0.9) will yield a
logarithm of low value (-0.1). While the flux control coefficient in the parasite
might be low (0.0009), the logarithm of the parasite flux control coefficient will
be high (-7.0). Substituting these values into the scaled effectivity equation
produces a value of 0.015. Therefore, the former reaction will make a better
drug target since the reaction in the parasite exerts more control over the flux
than the reaction in the host.
Analysis revealed that GAPDH, GlcTr and PFK were the best drug targets of
all the enzymes in the P. falciparum and erythrocyte70 glycolysis models with
scaled effectivities of 6.41, 5.84 and 3.63, respectively.
The differential control study was performed on GlcTr using cytochalasin B
as an inhibitor in P. falciparum with the aid of a custom made quench-flow
device2. The model was adjusted to simulate experimental conditions as Penkler
inhibited the GlcTr activity and measured its effect on lactate flux. The model
gave a good estimate of the flux control coefficient (a predicted value of 0.2
while 0.3 was experimentally measured).
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1.9 This study
The Penkler model of P. falciparum glycolysis incorporated the glycerol branch
in a single fitted rate equation, termed the glycerol dehydrogenase (GlrDH)
reaction, which was fitted to the experimentally measured glycerol flux. The
glycerol production pathway in P. falciparum consists of at least two enzymes
(G3PDH and GK) and a transport protein (aquaglyceroporin) (Fig. 1.1). The
present work has as goal to kinetically characterise the enzymes of the glycerol
branch with the aim of incorporating the kinetics into the Penkler model.
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Methods
In order to construct a detailed kinetic model on glycerol production in Plas-
modium falciparum, kinetic parameters (KM , Vmax, Keq) had to be obtained.
This chapter describes the cultivation and extraction procedures, as well as
how the kinetic assays were conducted and how the samples from the red blood
cell free trophozoite incubations with glucose were analysed.
2.1 Materials
All reagents, intermediates, and enzymes were purchased from Sigma-Aldrich
(Steinheim, Germany) except for Albumax II (Invitrogen Coorp., Auckland,
New Zealand), hexokinase/glucose-6-phosphate dehydrogenase (HK/G6PDH;
Roche, Mannheim, Germany), acetonitrile (Romil Ltd, Cambridge, United
Kingdom), and glycerol (Holpro Lovasz, Gauteng, South Africa). The following
reagents were all purchased from Merck (Darmstadt, Germany): sodium chlo-
ride, potassium chloride, di-potassium hydrogen orthophosphate, magnesium
sulphate heptahydrate, ammonium acetate, and perchloric acid, 70 %v/v.
2.2 Cultivation of Plasmodium falciparum
D10
P. falciparum D10 infected human red blood cells (A+; Western Cape Province
Blood Bank) were continuously cultured in RPMI-1640 culture medium71. The
cultures were incubated at 37 ◦C under an atmosphere of 3 % oxygen, 4 %
carbon dioxide and 93 % nitrogen19.
The RPMI-1640 culture medium was composed of RPMI medium, 0.5 %w/v
17
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Albumax II, 25 mM HEPES, 22 mM glucose, 25 mM sodium bicarbonate,
3 mM hypoxanthine and 0.05 g/L gentamicin sulphate72. The pH ranged from
7.2 - 7.3. The medium was sterilised by filtering it through a 0.22 µm pore size
filter and used within two weeks after preparation19.
To ensure that the cultures were synchronised 5 %w/v d-sorbitol was added
to 1.5-2.0 mL infected red blood cells73,19. The infected red blood cells were
centrifuged at 750 × g for 3 minutes and the supernatant aspirated. Sorbitol
(5 %w/v; 10 mL) was added to the infected red blood cells. The infected red
blood cell-sorbitol suspension was incubated in a 37 ◦C water bath for 10
minutes (inverted a few times every 2 minutes), centrifuged and aspirated as
before. The cells were washed once with culture medium before resuspension
in culture medium and deoxygenation with the gas mixture2. The cells were
periodically checked under the microscope to see whether the cultures were
synchronous. Seventy percent of the parasites were typically in the ring phase
after synchronisation.
2.3 Isolation of Trophozoite Stage Parasites
Once the parasitemia—the ratio of parasites to red blood cells—reached 10 %,
the trophozoites were isolated by centrifugation (750 × g) of the infected
red blood cells and resuspending them in culture medium. Under non-sterile
conditions saponin (final concentration 0.05 %w/v) was added to the suspension
which was centrifuged at 1800 × g for 7 min at room temperature74. The
supernatant was discarded and the isolated trophozoites were resuspended in
phosphate buffered saline (PBS) or culture medium (for the glucose incubation
assays) and centrifuged as before. The cells were washed twice with PBS or
culture medium.
For the glucose incubation assays (Section 2.6), the parasites were washed
twice with glucose-deficient incubation buffer (i.e. a modified Ringer buffer)
that contained 50 mM HEPES, pH 7.16, 120 mM NaCl, 1 mM MgCl2.6H2O,
10 mM KCl followed by equilibration with glucose-rich incubation buffer (5 mM
glucose) followed2.
Following the two PBS washes, and in preparation for enzyme kinetic assays
(Section 2.4), the trophozoites were washed twice with regular kinetic assay
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buffer (20 mM HEPES, pH 7.16, 20 mM MgCl2.6H2O, 10 mM KCl, 20 mM
NaCl)19. The supernatants of the final two wash steps were retained and
functioned as negative controls to ascertain whether uncontrolled lysis of
parasites occurred during those wash steps.
2.4 Enzyme Kinetic Assays
The enzyme kinetic assays were all performed in 96 well flat bottomed mi-
crotitre plates (Greiner Bio-One GmbH, Frickhouse, Germany) and the reactions
monitored online with a PowerWave 340 microtitre plate spectrophotometer
(BioTek Instruments Inc., Winooski, VT, USA). The computer program, Gen5
(v.1.05.11, BioTek Instruments Inc., Winooski, VT, USA), was used to record
the spectrophotometric data. The final assay volume was 100 µL in all assays
except for the Bradford protein determination assays (Section 2.8). The follow-
ing enzymes were assayed: G3PDH, GK and glycerol 3-phosphate-dependent
phosphatase (G3Pase).
2.4.1 Cell extract preparation
Trophozoite extracts of different concentrations were used for the kinetic pa-
rameter determinations of the various enzymes. For GK a 2× dilution of
trophozoites in kinetic assay buffer (Section 2.3) was made. While for G3PDH
and G3Pase the trophozoites were diluted 3 and 6 times, respectively. The
extracts were made by subjecting the suspended trophozoites to three freeze-
thaw cycles2 and centrifugation (10,000 × g, 5 min, 4 ◦C). The supernatant
was retained and kept on ice.
2.4.2 Glycerol 3-phosphate dehydrogenase
The methods described below were adapted from Nilsson30.
G3PDH activity was assayed by varying substrate concentrations NADH (0-0.36
mM) and DHAP (0-5.55 mM). Product inhibition by G3P (0-16.7 mM) in the
presence of NADH (0.36 mM) and DHAP (0.22 mM) was measured as well as
product inhibition by NAD+ (0-8.4 mM) with DHAP (5.55 mM) and NADH
(0.22 mM). Assays were performed in the presence of 4 mM 1,4-dithio-d-threitol
(DTT).
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2.4.3 Glycerol kinase
Three methods were used to detect GK activity. Commercial GK from rabbit
muscle (0.6 U/mL final concentration) was used as a positive control to make
sure that the coupled enzyme system functioned well.
Glycerokinase activity was measured by monitoring the phosphorylation of
glycerol (10 mM) spectrophotometrically75 at 340 nm by linking the enzyme’s
activity via ADP to pyruvate kinase (PK, 3 U/mL) and l-lactate dehydrogenase
(LDH, 3.4 U/mL). The initial concentrations of phosphoenolpyruvate (PEP),
NADH and ATP were 1.0 mM, 0.4 mM,and 2.0 mM, respectively.
The second method of detection that used to detect GK activity was adapted
from Wieland76. Briefly, GK activity, i.e. the phosphorylation of glycerol, was
linked to NAD+ reduction via commercial G3PDH (5 U/mL) and ATP (1.7 mM)
with subsequent production of DHAP and ADP. The initial concentration
of NAD+ was 0.7 mM. Absorbance was measured at 340 nm. Hydrazine
monohydrate (320 mM) was used to bind irreversibly to DHAP upon formation.
The third GK detection method observed the dephosphorylation of G3P by GK
via a hexokinase/glucose 6-phosphate dehydrogenase (HK:G6PDH; 5:2.5 U/mL)
enzyme-coupled system. The concentrations of glucose, ADP and NADP were
10, 1 and 10 mM, respectively, while the G3P concentration was 5 mM.
2.4.4 Glycerol 3-phosphate-dependent phosphatase
G3P-dependent phosphatase (G3Pase) activity was measured in two ways.
With the first method the aim was to (1) determine whether there was a
marked reproducible G3P-dependent increase in the concentrations of glycerol
and inorganic phosphate over the incubation period since reaction was expected
to be at equilibrium at the times when samples were taken and (2) shorten
the incubation time and the duration of the intervals between sampling times
to determine the initial rate of the reaction once reproducible results were
obtained in aim 1.
Trophozoite extract was therefore incubated with G3P (0, 5, 10, 20 mM) in
the presence of 4 mM DTT over a 50 minute period. Samples were taken at 0,
10, 20, 35, and 50 minutes after the reaction was initiated by the addition of
extract. Perchloric acid (6 % v/v final concentration) was used to quench the
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reaction and the samples were neutralised with 7 N KOH prior to centrifugation
(10000 ×g, 1 min). The samples were stored on ice and centrifuged collectively.
The supernatants of the samples were retained and diluted 5, 10 and 15 times
with kinetic assay buffer (Section 2.3).
The method of Barnett et al. 77 was used to colorimetrically analyse the inorganic
phosphate content of the samples’ supernatants. To a 50 µL sample in a well
of a Greiner Bio-One 96 well flat-bottomed microtiter plate was added 50 µL
colour reagent (1 vol. 3 M H2SO4 : 1 vol. 2.5 % w/v ammonium molybdate : 2
vol. d.i. H2O : 1 vol. 10 % w/v ascorbic acid). The plate was then incubated
for 90 minutes at 37 ◦C and read at 660 nm. To determine the concentration
of inorganic phosphate in the samples, a standard curve of K2HPO4 (0-2 mM)
was constructed.
The second method involved the online monitoring of inorganic phosphate
evolution by coupling the dephosphorylation of G3P (5 mM) to GAPDH (3.2
U/mL) reaction (see Fig. 1.1). The GAPDH reaction oxidises GAP (5 mM) to
1,3-bisphosphoglycerate (1,3BPG) while simultaneously reducing NAD+(2.5
mM) and phosphorylating the substrate with inorganic phosphate.
2.5 Model Construction
The original model for P. falciparum glycolysis was constructed by Penkler2,23.
The models were constructed in Wolfram Mathematica 8.0® and are available
on JWS Online (http://jjj.biochem.sun.ac.za)78,79. The data files and models
are also available on the SEEK platform80 in Mathematica notebook and SBML
formats23. The models are a set of ordinary differential equations that are
numerically integrated to obtain the steady state flux and internal metabolite
concentrations. In this study we followed a similar technique to incorporate
our experimentally measured enzyme kinetics in the existing model.
2.6 Model Validation
In order to validate the predictions of the model, isolated, erythrocyte-free
trophozoites were incubated in a 14C-glucose-rich incubation buffer (Section 2.3)
to determine the change in external metabolite (i.e. glucose, lactate, pyruvate
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and glycerol) concentration over time. The experiment was repeated with
unlabelled glucose-rich incubation buffer.
2.6.1 Incubation with 14C-glucose
Isolated trophozoites were incubated with 14C-glucose1 in order to determine
the concentrations of external metabolites more accurately with the aid of hy-
drophilic interaction liquid chromatography (HILIC)81. Once the trophozoites
were mixed with glucose-rich incubation buffer, 10 µL of the suspension was
sampled for cell counting (Improved Neubauer Haemocytometer). Another
aliquot was taken for total protein determination (Section 2.8). The incubation
was immediately mixed with the 14C-glucose (1:80 ratio) after which a sample
was taken (time point zero), centrifuged (5000 × g, 1 min) and the supernatant
added to acetonitrile (70 % v/v final concentration). Samples were taken in 15
and 30 minute intervals.
2.6.2 Sample analysis with HPLC
The method of Antonio et al. 82 was used to determine the concentrations of
the external metabolites: glucose, lactate, pyruvate and glycerol. Briefly, a
ZIC®-HILIC column (150 × 7.5mm, 5µm, 200Å, SeQuant™, Merck, Darmstadt,
Germany) fitted with a guard column (20 × 2.1mm, 5 µm, SeQuant™, Merck,
Darmstadt, Germany) on a high performance liquid chromatography (HPLC)
system was used to separate the analytes. The components of the HPLC
system were a SpectraSYSTEM P4000 pump (Thermo Separation™ products,
San Jose, CA, USA), a SpectraSYSTEM AS3000 auto-sampler (Thermo Sep-
aration™ products, San Jose, CA, USA) and a Flo-One liquid scintillation
spectrophotometer (Radiomatic, Tampa, FL, USA). The radioactive emissions
of the samples were recorded with HPLC Flo-One/Beta Data Acquisition soft-
ware (v. 2.0). The analogue intensity (V) data was analysed with Wolfram
Mathematica 8.0 ®.
The flow rate and injection volume were 1.0 mL/min and 100 µL. Separation
occurred at room temperature (25 ◦C). Mobile phase A consisted of acetonitrile
(0.1 % v/v formic acid) and mobile phase B of 5 mM ammonium acetate, pH
4 (0.1 % v/v formic acid). Before initiating the gradient elution profile, 90 %
1Samples were provided by Dr. Gerald Penkler.
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v/v A was pumped through the system for 1 minute—altering the method of
Antonio et al. 82 minutely.
2.6.3 Incubation with unlabelled glucose
The cells were packed by centrifugation (10000 ×g, 5 min) at room temperature.
The supernatant was discarded and the parasites resuspended in glucose-rich
incubation buffer. At time point (t0) two 10 µL aliquots for cell counting
(Improved Neubauer Haemocytometer) and total protein determination (Section
2.8) were taken immediately. Additional samples were taken 15, 30, 45, 60 and
90 minutes after initiation. The trophozoites in these time point samples were
pelleted by centrifugation (13000 rpm, 5 min) and the supernatant drawn off
and flash frozen with liquid nitrogen. The samples were stored at -80 ◦C and
enzymatically assayed. The cell pellets were frozen too and subjected to a
Bradford total protein determination assay (Section 2.8).
2.6.4 Enzymatic analyses of samples
External glucose concentration
In order to determine the concentration of glucose in the samples that were
taken during the incubation with unlabelled glucose, a standard curve was
constructed19. A series of standards ranging from 0 mM to 10 mM glucose was
made. Glucose standard (5 µL) was incubated with 95 µL glucose determi-
nation buffer for 30 minutes at 25 ◦C. The glucose determination buffer was
composed of 150 mM HEPES, pH 7.6, 15 mM MgSO4.7H2O, 4.5 mM ATP,
0.63 mM NADP, and 0.5 % v/v hexokinase/glucose-6-phosphate dehydrogenase.
Absorbance was read after 30 minutes of incubation on a PowerWave 340
microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA).
Likewise, 5 µL of sample (or dilution of sample) was incubated with 95 µL
glucose determination buffer and absorbance read at 340 nm after 30 minutes.
External lactate concentration
Lactate concentrations were determined in a similar manner (adapted from
Penkler19). A standard curve was set up with concentrations ranging from
0-10 mM sodium lactate. The lactate determination buffer was composed
of 320 mM hydrazine monohydrate, 4 mM NAD+ and 20 U/mL l-lactate
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dehydrogenase in addition to 150 mM HEPES, pH 7.6, and 15 mMMgSO4.7H2O.
Lactate determination buffer (95 µL) was added to 5 µL standard or sample
and the absorbance read after 90 minutes at 340 nm and 25 ◦C. Hydrazine
monohydrate binds irreversibly to pyruvate which, then, drives the reaction in
the direction of pyruvate formation.
External pyruvate concentration
The concentration of pyruvate in samples and standards were determined in a
manner similar to the way in which lactate concentrations were obtained. The
pyruvate determination buffer was composed of 150 mM HEPES, pH 7.6, 15 mM
MgSO4.7H2O, 0.8 mM NADH, and 15.8 U/mL l-lactate dehydrogenase. The
standard/sample was incubated at 25 ◦C for 30 minutes before the absorbance
was read at 340 nm. The pyruvate standard dilution series ranged from 0 to 2
mM.
External glycerol concentration
An adaptation of the method developed by Eggstein and Kuhlmann75 was used
to determine the glycerol concentration of standards (0-2 mM) and in samples.
After 30 minutes incubation at room temperature of a 5 µL sample/standard
with 95 µL glycerol determination buffer, the absorbance was read at 340 nm.
For the glycerol determination buffer, the HEPES/MgSO4.7H2O (150 mM/15
mM) buffer (pH 7.6) was supplemented with 1 mM PEP, 0.4 mM NADH, 1 mM
ATP, 3 U/mL PK, 3.6 U/mL LDH and 2 U/mL GK.
From absorbance to concentration
To determine the concentration of an external metabolite in a given sample, a
linear standard curve of known concentrations is constructed. Upon obtaining
the slope of the standard curve via linear regression, the metabolite-dependent
absorbance values of the samples are converted to concentration with the
Beer-Lambert law83.
Because glycerol and pyruvate standards absorbance values decrease with
increasing metabolite concentration as NADH is oxidised to NAD+, negative
concentration values arise when a sample’s absorbance value (As) is greater
than that of the 0 mM metabolite standard (A0) (Eq. 2.6.1). This standard’s
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. METHODS 25
absorbance value is subtracted from the absorbance value of all the other
standards and samples. Thus, negative concentration values are merely an
artefact of data processing and should not affect the product formation rate
adversely in any way.
∆Abs = −(As − A0) (2.6.1)
2.7 Metabolic Control analysis
Steady state analysis and metabolic control analysis were performed on the
model on JWS Online (http://jjj.biochem.sun.ac.za) by the author.
2.8 Bradford protein determination
The total protein in an extract was determined via the method of Bradford84
as modified by Penkler19. Briefly, a standard curve of bovine serum albumin (0-
1 mg/mL) was constructed by incubating 5 µL standard with 180 µL Bradford
Reagent (0.1g/L Coommassie Brilliant Blue G-250, 0.05 % v/v methanol, 8.5
% w/v H3PO4) for 15 minutes (at room temperature) and reading the plate 595
nm at the end of the 15 minute period. A dilution series of the extract was
made and incubated in the same way. The absorbance values were converted
to concentration with the aid of the standard curve and thus the protein
concentration in the extract was determined.
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Results and Discussion
This chapter presents the experimental results of the kinetic characterisation
of glycerol 3-phosphate dehydrogenase (G3PDH), detection of glycerol kinase
(GK) and G3P-dependent phosphatase activity as well as the partial validation
of the kinetic model which was constructed by Penkler et al.23. A description
of the kinetic model is presented along with the findings of metabolic control
analysis that was performed on the model.
3.1 Enzyme Kinetics
3.1.1 Glycerol 3-phosphate dehydrogenase
Glycerol 3-phosphate dehydrogenase (G3PDH) reduces DHAP to G3P while
simultaneously oxidising NADH to NAD+. A random order bi-substrate rate
equation85 (Eq. 3.1.1) was fitted simultaneously to all the data.
vG3PDH =
VfG3PDH
dhap
Kdhap
nadh
Knadh
(1 + dhap
Kdhap
+ g3p
Kg3p)(1 +
nadh
Knadh
+ nad
Knad
)
(3.1.1)
P. falciparum G3PDH was not observed to be sensitive to inorganic phosphate,
in contrast to yeast G3PDH28,29, as seen by the maximum specific activity
measured in the presence and absence of 1 mM KH2PHO4: 0.0351 ± 0.005
µmol.min−1.mg−1 protein vs. 0.0345 ± 0.006 µmol.min−1.mg−1 protein.
The fitting of Eq. 3.1.1 to the kinetic data yielded KDHAP and KNADH values
of 0.340 ± 0.040 mM and 0.090 ± 0.009 mM, respectively (Table 3.2). The
substrate saturation curves are shown in Fig. 3.1 A & B. No kinetic data
for G3PDH of P. falciparum could be found in the scientific literature. The
kinetic data for a number of other organisms (T. brucei (blood stream forms),
26
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L. mexicana (recombinant), Debaromyces hansenii and rabbit muscle) was
collected from the scientific literature27,32,30 and the average values of the
kinetic constants for these organisms were calculated. Compared to the values
from the scientific literature, the KDHAP and KNADH values determined in this
present study were 1.5 to 3 times higher.
For the forward reaction, i.e. the reduction of DHAP to G3P, the maximum spe-
cific activity of G3PDH was measured to be 0.0423 ± 0.0052 µmol.min−1.mg−1
protein (n = 5). However, the maximum specific activity of G3PDH in the
manuscript in Appendix A was measured to be 0.06 ± 0.01 µmol.min−1.mg−1
protein. A possible for this discrepancy might be the higher hemoglobin con-
tents of the extracts used in the determination of the maximum specific activity
in this present study. The maximum specific activity that appears in the
manuscript was measured independently from this present work.
The maximum specific activity of the reverse reaction was 0.0034 ± 0.0003
µmol.min−1.mg−1 protein (n = 4). It comes as no surprise since theKeq (3260086)
indicates that the enzyme favours the forward reaction. This finding was cor-
roborated by previous studies in a variety of organisms29,30,87.
Since the reverse reaction was very slow compared to the forward reaction, the
KM of G3PDH for its products were determined via product inhibition studies.
Product inhibtion by G3P was measured at 0.22 mM DHAP and 0.358 mM
NADH while that by NAD+ was determined at 0.22 mM NADH and 5.55 mM
DHAP. These yielded a KG3P of 3.98 ± 1.93 mM and a KNAD of 0.513 ± 0.123
mM which are more than those of L. mexicana, T. brucei and rabbit muscle32,
for example (Table 3.1). The fits are shown in Fig. 3.1 C & D.
3.1.2 Glycerol kinase
Three different assay methods were used to detect GK activity. Two of these
assay methods measured the activity of GK in the direction of glycerol to G3P
conversion. The first assay method linked ADP formation to NADH oxidation
through the action of pyruvate kinase and lactate dehydrogenase assay. The
second assay method linked G3P formation directly to NADH oxidation through
the action of G3PDH. The third assay method detected GK activity by coupling
ATP formation (and thus the dephosphorylation of G3P) to NADPH formation
through the activity of hexokinase and glucose-6-phosphate dehydrogenase.
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Table 3.1: Summary of the kinetic parameters for P. falci-
parum glycerol-3-phosphate dehydrogenase. The kinetic data of G3PDH
were combined, normalised to Vmax (Fig. 3.1) and fitted simultaneously
to Eq. 3.1.1. In addition to the fitted parameters (± asymptotic error)
shown below, KM of G3PDH for its substrates and products were taken
from the literature. These values are presented as mean ± standard
error of the mean (SEM).
Parameter Fitted Value Literature Valuea Reference
VfG3PDH
b 0.0423 ± 0.0052c — —
KDHAP (mM) 0.340 ± 0.040 0.222 ± 0.082 27,32,30
KNADH (mM) 0.090 ± 0.009 0.014 ± 0.004 27,32,30
KG3P (mM) 3.98 ± 1.93 1.333 ± 0.088 27,32,30
KNAD (mM) 0.513 ± 0.123 0.347 ± 0.440 27,32,30
Keq — 32600 86
a Values from 5 different organisms (i.e. T. brucei (blood
stream form), L. mexicana (recombinant enzyme), Debaromyces
hansenii, Saccharomyces cerevisiae and rabbit (muscle))
were used to compute the literature value of KDHAP and
KNADH while KG3P and KNAD are the mean ± SEM of 4
independent organisms.
b Specific activity was measured in µmol.min−1.mg−1 protein.
c The maximal specific activity from five independent experiments.
Mean ± SEM shown.
Table 3.2: Comparison of P. falciparum KG3P and KNAD to values from the
scientific literature. The KG3P and KNAD of P. falciparum G3PDH generated in
this study are compared to those obtained by Marché et al. 32 for the indicated
organisms.
KG3P (mM) KNAD(mM) Reference
P. falciparum 3.98 0.513 -
L. mexicana 1.7 0.42 32
T. brucei 2.25 0.32 32
rabbit muscle 0.18 0.012 32
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A
B
C
D
Figure 3.1: Biochemical characterisation of P. falciparum G3PDH. G3PDH
catalyses the NADH-dependent reduction of dihydroxyacetone phosphate to
form glycerol 3-phosphate and NAD+. Saturation curves with DHAP (A) and
NADH (B) are shown in addition to the inhibition of G3P (C) and NAD+ (D). A
random order bi-substrate rate equation (Eq. 3.1.1) was fitted simultaneously to
all the data and described the data well (adjusted R2 = 0.94). Parameter values
obtained from the fitting are shown in Table 3.2. The error bars represent SEM,
where n = 4 (A), n = 4 (B), n = 5 (C) and n = 2 (D) independent experiments
and the shaded area indicates the 95% confidence interval.
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GK activity could not be measured with the two methods for the reaction in the
direction of glycerol to G3P. Positive controls were made for both methods using
commercial GK. A minimal activity of 0.003 µmol.min−1.mg−1 protein would
have been detected in the assay.
When the dephosphorylation of 5 mM G3P was monitored using commercial
hexokinase and glucose-6-phosphate dehydrogenase as coupling enzymes, low
level GK activity was observed (Fig. 3.2). The background activity was
high (0.0301 ± 0.0008 µmol.min−1.mg−1 protein) in the first 7 minutes of the
reaction after which it increased to 0.0377 ± 0.0004 µmol.min−1.mg−1 protein.
Subtracting the background activity from the G3P-dependent activity yielded
a GK rate of 0.0034 µmol.min−1.mg−1 protein.
With the aid of an ATP standard curve, it was determined that the enzyme-
coupled system used was sensitive enough to measure ATP concentrations as
low as 10 µM. To fully convert 10 µM G3P to 10 µM ATP will take GK (with
a specific activity of 0.0034 µmol.min−1.mg−1 protein) at least 7.5 minutes.
Naidoo and Coetzer 47 knocked out the GK gene in the P. falciparum 3D7 strain
to determine whether GK is essential to parasite growth. In their radiolabel
study, they incubated late stage trophozoite wild type and 3D7∆PfGK para-
sites with 14C-glycerol for 4 hours at 37◦C. The knockout parasites incorporated
50 % less 14C-glycerol into PE and PC than the wild type strain. This suggests
that GK plays a role in glycerol incorporation but is not essential, and that
another pathway for the incorporation of 14C-glycerol exists.
3.1.3 G3P-dependent phosphatase
The measured activity of 0.0034 µmol.min−1.mg−1 protein for GK in the
direction of glycerol formation is very low compared to specific activities for
glycolytic enzymes in P. falciparum. Although the flux through the glycerol
pathway is much lower than the glycolytic flux an attempt was made to detect
G3P-dependent phosphatase activity in trophozoite extracts.
With a colorimetric assay for inorganic phosphate77 and an enzyme-coupled
assay for glycerol75, the G3P-dependent release of inorganic phosphate and
glycerol could be detected in two independent experiments (Fig. 3.3). Figure
3.3 A clearly shows inorganic phosphate formation in the presence of G3P
and none in the absence of this substrate. Specific activities ranging from
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Figure 3.2: Progress curve of P. falciparum glycerol kinase activity. Shown
are lysate activities in the presence () and absence ( ) of G3P (5 mM). The
error bars represent SEM of two independent experiments each conducted in
triplicate.
0.3174 to 0.4326 µmol.min
−1
.mg
−1
protein in the presence of G3P (5-20 mM)
were observed (Table 3.3). The enzyme showed little G3P dependence above 5
mM. This might be due to the enzyme being saturated at G3P concentrations
exceeding 5 mM.
The glycerol formation progress curves (Fig. 3.3 B) did not follow the same
pattern as inorganic phosphate formation neither do they agree stoichiometri-
cally.
The first experiment was performed in a technical triplicate but it was not
possible to fully reproduce the results (Fig. 3.3 A & B) in a second independent
experiment (Fig. 3.3 C & D). A 5 fold decrease in inorganic phosphate
concentration was observed which might be due to a lower parasite yield than
expected or an experimental error. There was little stiochiometric consistency
between inorganic phosphate and glycerol concentration measurements within
an experiment as well as between the two experiments.
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Table 3.3: Glycerol-3-phosphate-dependent inorganic phosphate and
glycerol formation rates. G3P was added to trophozoite extract. Samples
were taken at 0, 5, 10, 15, 35 and 50 minutes. The inorganic phosphate
concentrations in the samples were determined colorimetrically77 while
their glycerol concentration were obtained via a coupled enzyme assay75.
The two independent experiments were conducted in singleton.
G3P (mM) Experiment 01 Experiment 02
Pi Ratea Glycerol Rate Pi Rate Glycerol Rate
0 0.0027 0.5615 0.0057 -0.1549
5 0.3174 1.2626 -0.0352 -0.2766
10 0.3993 -0.6285 0.1668 0.8436
20 0.4326 0.0966 0.09420 0.3122
a The rates shown here have units of µmol.min−1.mg−1 protein.
Due to the unreliability of this data, our findings of G3P-dependent phosphatase
activity in the extract of P. falciparum trophozoites are inconclusive and merely
preliminary.
When G3P-dependent release of inorganic phosphate was coupled to glycer-
aldehyde 3-phosphate dehydrogenase, enzyme activity was not detected.
3.2 Incorporation into glycolysis model
For the G3PDH rate equation (Eq. 3.1.1) to be incorporated1 into the detailed
kinetic model (Penkler 1 model23), it was rewritten in the form:
vG3PDH =
VG3PDH ·VPf ·α· DHAP [t]KDHAP ·VPf
NADH[t]
KNADH ·VPf (1−
G3P [t]·NAD[t]
DHAP [t]·NADH[t]·Keq )(
1+ DHAP [t]
KDHAP ·VPf
+ G3P [t]
KG3P ·VPf
)(
1+ NADH[t]
KNADH ·VPf
+ NAD[t]
KNAD ·VPf
) (3.2.1)
where the factor α is the ratio of parasite cytosolic volume to total protein (4.67
µL cytosol.mg protein−1) and VPf is the trophozoite cytosolic volume (assumed
to be 28 fL)2. By multiplying the Vmax by these factors its units change
from µmol.min−1.mg−1 protein to mmol.min−1.L cytosol−1. By dividing each
metabolite by VPf , one can model in terms of mole quantity instead of (molar)
concentration which simplifies the incorporation of the P. falciparum glycolysis
1The modelling work in Section 3.2 was performed by G. Penkler, Ph.D., who uploaded
the model onto JWS Online (http://jjj.biochem.sun.ac.za).
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A
B
C
D
Figure 3.3: Progress curves of glycerol 3-phosphate-dependent inorganic phos-
phate and glycerol formation. The assays were initiated when 0 ( ), 5 (), 10
() or 20 (N) mM G3P was added to trophozoite extracts at 37◦C. Samples were
taken at 0, 10, 20, 35 and 50 minutes, and subjected to inorganic phosphate77
(A & C) and glycerol75 (B & D) analyses. Two independent experiments were
performed in singleton while samples were analysed in triplicate. The error bars
indicate SEM of these technical triplicates.
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model as a compartment in an erythrocyte glycolysis model. The metabolites
are represented as time-dependent variables2.
Because of the low GK rate, G3P dephosphorylation to glycerol (Glr) was
modeled as a mass action equation (Eq. 3.2.2) that also incorporates Glr
export since P. falciparum aquaglyceroporin relies on mass-action kinetics20,21.
Operating under the assumption of rapid G3P dephosphorylation and transport
of Glr, the kGlrTr was set to 1 min−1 23.
vGlrTr = kGlrTr ·
(
G3P [t]
VPf
− Glrext[t]
VRBC
)
(3.2.2)
where VRBC is the external volume. In the model all external metabolites (i.e.
in the erythrocyte) are divided by VRBC .
The model consists of 19 ordinary differential equations (ODEs)23 which describe
changes in external (i.e. glucose, lactate, pyruvate and glycerol) and internal
(e.g. DHAP, G3P) metabolite concentrations as a function of time and enzyme
rates.
In this section only the ODEs and rate equations for the metabolites in the
glycerol branch are shown. Equations 3.2.3 - 3.2.5 are the ODEs of DHAP,
G3P and Glrex while Eq. 3.2.6 and 3.2.7 are the time-dependent rate equations
of aldolase (ALD) and triose phosphate isomerase (TPI). Aldolase cleaves
fructose-1,6-bisphosphate (F1,6BP) into DHAP and GAP while TPI catalyses
the isomerisation of DHAP to glyceraldehyde-3-phosphate (GAP).
DHAP ′[t] = vALD − vTPI − vG3PDH (3.2.3)
G3P ′[t] = vG3PDH − vGlrTr (3.2.4)
Glr′ex[t] = vGlrTr (3.2.5)
vALD =
VALD·VPf ·α· F1,6BP [t]KF1,6BP ·VPf ·(1−
DHAP [t]·GAP [t]
F1,6BP.Keq )
1+ F1,6BP [t]
KF1,6BP ·VPf
+ DHAP [t]
KDHAP ·VPf
+ GAP [t]
KGAP ·VPf
+ DHAP [t]·GAP [t]
KDHAP ·VPf ·KGAP ·VPf
(3.2.6)
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vTPI =
VTPI · VPf · α · DHAP [t]KDHAP ·VPf ·
(
1− GAP [t]
Keq·DHAP [t]
)
1 + DHAP [t]
KDHAP ·VPf +
GAP [t]
KGAP ·VPf
PEP [t]
KiPEP ·VPf
(3.2.7)
3.3 Model validation
To validate the model (Penkler 1 model), it was adapted to function as a closed
system (Penkler 2 model) so that its predictions of the glucose consumption
and product formation rates could be compared to experimentally determined
rates23. The validation evaluates the accuracy of the enzyme kinetics upon
which the model (Penkler 1 model) is based.
The external metabolites (glucose, lactate, pyruvate, and glycerol) were made
time-dependent variables, i.e. metabolite[t]. The initial external glucose con-
centration was raised to 5 mM while the other external metabolites were set to
zero. The initial concentrations of the internal metabolites were all set to 0.1
mM while the ATP and NADH moieties remained equal to 3 mM. The initial
ratios of ATP:ADP and NADH:NAD were set to 1.
The model predicted the glucose flux JGLC to be 0.05 µmol.min−1.mg−1 protein,
JLAC 0.092 µmol.min−1.mg−1 protein, JPY R 0.004 µmol.min−1.mg−1 protein and
JGLR 0.004 µmol.min−1.mg−1 protein. These predictions agree well with the
experimentally measured fluxes that were obtained when erythrocyte-free, intact
trophozoites were incubated with 14C radiolabelled and unlabelled glucose (see
Table 3.4).
Erythrocyte-free, intact trophozoites were incubated with 14C-glucose for 90
minutes during which samples were taken to quantify the external metabolite
concentrations (see Section 2.6.1). These samples were provided by G. P.
Penkler for HPLC analysis by the author. The retention times of the external
metabolites lactate, pyruvate, glycerol and glucose were 6.5, 10.1, 10.4 and
13.4 minutes, respectively. In Fig. 3.4 one can clearly see the elution profiles
of the external metabolites changing over time with total decrease om the
glucose forming predominantly lactate, with glycerol and pyruvate as minor
metabolites.
The analysis showed a pyruvate:glycerol ratio close to 1, i.e. 0.92 ± 0.23 (SD,
n =7)2. Therefore, when the peaks of these two closely eluting metabolites
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Table 3.4: Comparison between experimental and model predictions of the
steady state fluxes. The external metabolites produced during an incubation
of intact trophozoites with 5 mM glucose were measured via enzyme-coupled
assays. The steady state fluxes (± SEM; for 12C-glucose, n =3; for 14C-glucose,
n = 2) were determined by linear regression, sampling at least 30 minutes.
The experimental fluxes are compared to the predictions of Penkler’s model
of P. falciparum glycolysis23. Model predictions were obtained by setting the
concentrations of external glucose (5 mM), lactate (1 mM), glycerol (0.2 mM)
and pyruvate (0.15 mM).
12C-Glucose 14C-Glucose Model
Flux Incubation Incubation Prediction
Mean (SEM) Mean (SEM)
µmol
min·mg protein
µmol
min·mg protein
µmol
min·mg protein
JGLC 0.050 (0.006) 0.045 (0.002) 0.05
JLAC 0.109 (0.005) 0.081 (0.003) 0.092
JPY R 0.004 (0.001) 0.004 (0.0007) 0.004
JGLR 0.003 (0.001) 0.005 (0.0005) 0.004
JPY R : JGLR 1.5 0.8 1
were inseparable, a ratio of 1:1 was assumed. The ratio of their production
rates was close to 1 too, i.e. JPY R : JGLR = 0.8.
Integration of the chromatograms yielded metabolite concentrations. Linear
regression over a minimum period of 30 minutes yielded consumption and
production rates of 0.045 ± 0.002 µmol.min−1.mg−1 protein for JGLC , 0.081
± 0.003 µmol.min−1.mg−1 protein for JLAC , 0.004 ± 0.0007 µmol.min−1.mg−1
protein for JPY R and 0.005 ± 0.0005 µmol.min−1.mg−1 protein for JGLR. These
are the average rates (mean ± SEM) of two independent incubations. It was
assumed that the system was in steady state after 30 minutes’ incubation.
Similar rates were obtained for the incubations with unlabelled glucose (n =
3): JGLC = 0.050 ± 0.006 µmol.min−1.mg−1 protein, JLAC = 0.109 ± 0.005
µmol.min−1.mg−1 protein, JPY R = 0.004 ± 0.001 µmol.min−1.mg−1 protein and
JGLR = 0.003 ± 0.001 µmol.min−1.mg−1 protein.
These rates, however, were normalised to previous lactate production rate
measurements due to a 3-fold overestimation of these rates which resulted from
an inherent error to account for all viable trophozoites. Figure 3.5 shows the
changes in external metabolite concentrations over time.
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Figure 3.4: Representative time progression HPLC chromatograms following
the metabolism of 14C-glucose (Glc) in P. falciparum trophozoites to the 14C-
labelled intermediates lactate (Lac), pyruvate (Pyr) and glycerol (Glr).
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Although the pyruvate:glycerol flux ratio was close to 1, i.e. JPY R : JGLR = 1.5,
the absolute concentration of pyruvate and glycerol differ strongly, in contrast
to measurements in the radioisotope experiments above. This discrepancy
between the radiolabelled and unlabelled experiments can be ascribed to the
negative pyruvate concentration values, an artefact of the enzymatic analysis
process. Yet despite this disagreement, the experimentally measured fluxes
agreed well with the model predictions. The concentration ranges of glycerol
and pyruvate have been offset by -0.69 mM and 0.37 mM, respectively, in
Fig. 3.5 to facilitate the comparison between the experimentally determined
fluxes and those predicted by the model. The model prediction for glycerol and
pyruvate production rates are quite accurate, although the model prediction for
the final concentration is lower. The model prediction for glucose consumption
and lactate production is not as accurate, mostly due to a difference in initial
conditions for glucose: an initial concentration of 5 mM was chosen and products
were initialised at 0 mM.
3.4 Metabolic Control Analysis
This thesis mainly focused on the kinetics of P. falciparum G3PDH and the
steady state pathway flux to glycerol. To understand the importance of
G3PDH on the flux through the pathway, metabolic control analysis (MCA)
was performed on the system.
Presented in Table 3.5 are the steady state predictions of the detailed kinetic
(Penkler 1) model. These steady state predictions were generated on JWS
Online (http://jjj.biochem.sun.ac.za) by the author. Of interest are the steady
state concentrations of DHAP, G3P, NADH and NAD+ which are 1.271, 0.557,
0.059 and 2.941 mM, respectively, as well as the steady state fluxes of glucose
transporter (GlcTr), ALD, TPI and G3PDH which have values of 0.04929,
0.04929, 0.04549, and 0.0038 µmol.min−1.mg−1 protein, respectively.
One can reduce the system to three reactions centred around the branch
point metabolite DHAP: the supply block of upper glycolysis (represented by
JGlcTr = JALD) and the two branches of the glycerol pathway (represented
by JG3PDH) and lower glycolysis (represented by JTPI). This rationale was
presented by Snoep et al. 88 and Sauro 89 90,91 when they analysed branched
systems.
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A
B
C
D
Figure 3.5: Progress curves of external metabolite concentrations. Isolated P.
falciparum trophozoites were incubated with glucose and the concentrations of
external metabolites were determined from samples taken over a 90 minute period.
External glucose (A), lactate (B), glycerol (C) and pyruvate (D) concentrations
were measured spectrophotometrically at 340 nm via enzyme-coupled assays.
The concentration ranges of glycerol (C) and pyruvate (D) were offset by -0.69
mM and 0.37 mM, respectively, due to a glycerol concentration of 0.69 mM
and a pyruvate concentration of -0.37 mM at 0 minutes. The mean ± SEM of
three independent experiments are shown. The solid line represents the model
prediction over this 90 minute time period.
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Table 3.5: Kinetic model predictions of steady state concentrations and fluxes.
Summarised below are the predictions of the P. falciparum glycolysis (Penkler1)
model for the steady state fluxes and metabolite concentrations. These steady
state predictions were generated on JWS Online (http://jjj.biochem.sun.ac.za)
by the author.
Metabolite Concentration (mM) Flux Rate
mM µmol.min−1.mg−1 protein
ADP 0.51 JALD 0.04929
ATP 2.49 JATPASE 0.09098
B1,3PG 0.001 JENO 0.09478
DHAP 1.271 JG3PDH 0.0038
F1,6BP 1.372 JGAPDH 0.09478
F6P 0.297 JGLCtr 0.04929
G3P 0.557 JGlrTr 0.0038
G6P 0.967 JHK 0.04929
GAP 0.055 JLACtr 0.09098
GLC 1.001 JLDH 0.09098
LAC 2.902 JPFK 0.04929
NAD+ 2.941 JPGI 0.04929
NADH 0.059 JPGK 0.09478
P2G 0.056 JPGM 0.09478
P3G 0.578 JPK 0.09478
PEP 0.061 JPY Rtr 0.0038
PYR 1.125 JTPI 0.04549
In their respective treatises they highlighted an important feature of branched
systems, i.e. when the flux through a downstream branch is much smaller than
the main flux, the enzymes in that branch will tend to have a high control of
the flux through that branch. Thus, the sum of the flux control coefficients
of the enzymes in a branch with negligible flux will be 188. It is tempting to
think that the glycerol pathway is such a negligible branch but with a flux
that is 7.7% of the GlcTr flux, the pathway is not quite negligible. This shows
the importance of flux ratios in control analysis, another feature of branched
systems. In linear systems flux ratios are irrelevant since there is only one
steady state flux through the system.
Analysis of G3PDH yielded a flux control coefficient of 0.6552, a value much
lower than 1. By using the approach set out by Sauro 89 (see Equation 3.4.1), one
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can calculate the flux control coefficient of G3PDH for its own flux (CJvG3PDHvG3PDH ).
The approach does not assume that the flux through the glycerol pathway
is negligible and makes use of flux ratios (α = JvG3PDH
JALD
and 1 − α = JvTPI
JALD
)
and elasticitiy coefficients (where vALDDHAP = −1.810, vG3PDHDHAP = 0.234 and
vTPIDHAP = 17.687). Application of this approach yielded a predicted flux control
coefficient of 0.99, still closer to 1 and higher than the actual CJvG3PDHvG3PDH .
CJvG3PDHvG3PDH =
vALDDHAP − vTPIDHAP · (1− α)
vALDDHAP − vG3PDHDHAP · α− vTPIDHAP · (1− α)
(3.4.1)
The discrepancy between the actual flux control coefficient and the predicted
value may be attributed to the theory assuming that only one branch point
metabolite (DHAP) exists when the pathways really share more than one (i.e.
NAD(H)). Thus, any analysis will have to consider NAD(H) too.
For an enzyme to have a flux control of 1 over its own flux, all its substrates,
products and effects have to remain constant when a small perturbation in
the enzyme is made. This means that for any change that occurs in G3PDH,
the concentrations of its substrates (DHAP and NADH) and products (G3P
and NAD+), the enzyme’s only effectors, have to remain constant. One can
therefore determine how much each effector contributes to the lessening of the
control G3PDH exerts over its own flux. One does this by adding the effects of
changes in DHAP, NADH, G3P and NAD+ to the flux control coefficient of 1.
In MCA terms this translates to adding the product of the concentration control
coefficient and elasticity of G3PDH for each of its effectors to the predicted
G3PDH flux control coefficient of 1 (as in Equation 3.4.2). The elasticity and
concentration control coefficients are presented in Table 3.6.
CJvG3PDHvG3PDH = 1 + CDHAPvG3PDH · vG3PDHDHAP + CG3PvG3PDH · vG3PDHG3P
+ CNADHvG3PDH · vG3PDHNADH + CNADvG3PDH · vG3PDHNAD (3.4.2)
Our analysis shows that the contribution of NADH (-0.2955) strongly dominates
those of DHAP (-0.0302), G3P (-0.0141) and NAD+ (-0.0051) (see Table 3.6).
Thus, NADH is responsible for lessening the control G3PDH exerts over its own
flux due to the enzyme’s high elasticity for this metabolite and the reasonably
strong concentration control on this metabolite.
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Table 3.6: Contribution of each G3PDH substrate and product to the enzyme’s
flux control coefficient. Presented here are elasticities of G3PDH for each
substrate or product and the concentration control coefficients of G3PDH on
these metabolites. The elasticities and concentration control coefficients were
determined on JWS Online (http://jjj.biochem.sun.ac.za). The contribution each
metabolite makes to lessing the control of G3PDH over the enzyme’s own flux is
determined by the product of the elasticity and concentration contol coefficients
of G3PDH for that metabolite.
vG3PDHDHAP 0.2343 CDHAPvG3PDH -0.1289 vG3PDHDHAP · CDHAPvG3PDH -0.0302
vG3PDHNADH 0.9121 CNADHvG3PDH -0.3240 vG3PDHNADH · CNADHvG3PDH -0.2955
vG3PDHG3P -0.0294 CG3PvG3PDH 0.4788 vG3PDHG3P · CG3PvG3PDH -0.0141
vG3PDHNAD -0.7774 CNADvG3PDH 0.0065 vG3PDHNADH · CNADvG3PDH -0.0051
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General Discussion
The present work set out to: 1) determine the kinetic parameters (KM and
Vmax) of Plasmodium falciparum glycerol 3-phosphate dehydrogenase (G3PDH),
2) detect glycerol kinase (GK) activity in asexual P. falciparum and determine
whether the parasite uses a phosphatase mechanism to dephosphorylate glycerol
3-phosphate (G3P), 3) update the existing Penkler model with the measured
kinetic data, and finally to 4) ascertain the distribution of control over the
steady state flux through the glycerol branch.
The kinetic characterisation of G3PDH was successfully completed. To the
author’s knowledge, this study marks the first kinetic description of the NAD+-
dependent G3PDH of P. falciparum in the scientific literature.
The results concerning the conversion of G3P to glycerol were inconclusive.
Although low level GK activity was detected, the background activity was
very high. If it is the case that P. falciparum GK does function in reverse,
i.e. dephosphorylating G3P to glycerol, in the intra-erythrocytic stage of the
parasite’s life cycle, the behaviour would be similar to that of T. brucei GK
which also catalyses the thermodynamically unfavourable reverse reaction in
the blood stage form of T. brucei 92,93. A reason for T. brucei GK catalysing the
thermodynamically unfavourable reaction was advanced by Krakow and Wang 93
who proposed that GK dephosphorylated G3P by mass action due to high
concentrations of G3P and ADP and an efficient ATP trap in the glycosome.
Králová et al. 94 found that T. brucei only used GK to dephosphorylate G3P
under anaerobic conditions. Under aerobic conditions, a G3P:DHAP shuttle
functioned to recycle DHAP.
Efforts to detect G3P-dependent phosphatase activity in the extract were
irreproducible and inconclusive. Given a shorter incubation time and intervals
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between sampling times, one might have been able to compare the initial rates
of the reaction and draw conclusions from the comparison. However, one cannot
rule out the activity of the non-specific phosphatase discovered by Hills et al. 50 .
The kinetic parameters that were obtained during the biochemical characterisa-
tion of G3PDH were incorporated into an existing model of P. falciparum gly-
colysis (Penkler 1 model; Appendix A) which is available on JWS Online23,78,79
(http://jjj.biochem.sun.ac.za). For model validation, the Penkler 1 model was
changed to reflect experimental conditions (Penkler 2 model —also available on
JWS Online) during which saponin-derived trophozoites were incubated with
radiolabelled and unlabelled glucose. The model predicted the steady state
fluxes of external metabolites glucose, lactate, pyruvate and glycerol. These
predictions compared well with the experimentally measured fluxes.
This glycolysis model is the first of its kind for P. falciparum. Similar bottom
up approach kinetic models of glycolysis exist, e.g. in yeast95, human erythro-
cyte70 and T. brucei 96,92. A kinetic model describing the glycerophospholipid
metabolism of P. knowlesi exists, but the researchers constructed the model
based on flux balance analysis62.
Metabolic control analysis was used to determine the distribution of flux control
over the glycerol branch in the updated Penkler 1 model. The analysis showed
that the NADH concentration greatly influenced the control of G3PDH over
the enzyme’s own flux. In this way glycolysis is able to control the magnitude
of the flux flowing through the glycerol branch. Unlike the simple pathway used
by Snoep et al. 88 and Sauro 89 to explain the theory of branch point analysis,
the glycerol branch is not negligible as shown by its elasticity coefficients for
DHAP and NADH as well as its flux ratio.
The fact that NADH exercises a significant amount of control over the flux
through G3PDH means that an increase in its concentration will result in an
increase in the flux through G3PDH thereby recycling the NAD+ for use by
glycolysis. P. falciparum also possesses mitochondrial G3PDH which implies the
presence of a G3P Shuttle. The G3P Shuttle, first reconstructed in rat kidney
mitochondria97, functions to transport reducing equivalents from cytosolic
NADH to mitochondrial NADH where they are used by the parasite’s electron
transport chain. Cytosolic NAD+ is recycled in the process22.
In a purely linear pathway, e.g. glucose conversion to lactate, there is no degree
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of freedom in terms of redox balancing. All glucose must be converted to
lactate or else there is no redox balance. A branched pathway in which the final
product has a different degree of reduction than glucose, offers different ways
of maintaining the redox balance. For instance, if a cell needs to make lipids
via G3P, then there would quickly be a shortage of NADH and the cell would
not be able to make lactate as the final product. Pyruvate would accumulate.
Via the flexibility of glycerol and pyruvate production the parasite can balance
redox metabolism, even if products are made that do not have the same degree
of reduction as glucose.
A similar situation is observed in Trypanosomatids (T. brucei, T. gambiense,
T. equiperdum and T. evansi) that convert glucose to glycerol and pyruvate in
equimolar amounts under anaerobic conditions94,98. Under aerobic conditions
when the G3P:DHAP shuttle is active in the micro-aerophilic parasite, T. brucei
brucei produced pyruvate and glycerol in a 3:1 ratio98.
Would G3PDH serve as a good drug target since the enzyme and the glycerol
branch (of which it is a part) are at a junction between glucose catabolism and
lipid metabolism? Based on the MCA results, inhibition of G3PDH would have
a significant effect on the flux through the lactate transporter (and therefore
lower glycolysis) because of the accumulation of DHAP and NADH in the
parasite. Whether lipid metabolism will be affected adversely requires further
study since Naidoo and Coetzer 47 showed that P. falciparum is able to acquire
and use glycerol from the surrounding medium even in the absence of GK.
Although not particularly relevant to the systems biology approach, further
study is needed to ascertain biophysical and other biochemical properties of
P. falciparum G3PDH since very little information in the literature exists on
the enzyme. P. falciparum aquaglyceroporin and GK have been extensively
characterised but not G3PDH.
Future studies also include expanding the Penkler model of P. falciparum gly-
colysis to include the pentose phosphate pathway, making the model a com-
partment of erythrocyte glycolysis, formatting it to simulate parasite growth,
and studying how malaria affects its human host’s homeostasis.
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Appendix A
Published Results
The G3PDH kinetic data generated during this study was incorporated into
Penkler et al. 23 . I was responsible for generating the kinetic data which was
combined with those of the first and second authors of this paper.
47
Stellenbosch University  https://scholar.sun.ac.za
Construction and validation of a detailed kinetic model of
glycolysis in Plasmodium falciparum
Gerald Penkler1,2, Francois du Toit1, Waldo Adams1, Marina Rautenbach1,
Daniel C. Palm1, David D. van Niekerk1 & Jacky L. Snoep1,2,3∗
December 11, 2014
1 Abstract
The enzymes in the Embden-Meyerhof-Parnas pathway of Plasmodium falciparum trophozoites
were kinetically characterised and their integrated activities analysed in a mathematical model.
For validation of the model we compared model predictions for steady state fluxes and metabolite
concentrations of the hexose phosphates with experimental values for intact parasites. The
model, which is completely based on the experimentally determined enzyme kinetic parameters,
gives an accurate prediction of the steady state fluxes and intermediate concentrations. This
is the first detailed kinetic model for glucose metabolism in P. falciparum, one of the most
prolific malaria-causing protozoa, and the high predictive power of the model makes it a strong
tool for future drug target identification studies. The modelling workflow is transparent and
reproducible and completely documented in the EuroSEEK platform, where all experimental
data and models are available for download.
Database
The mathematical models described here have been submitted to the JWS Online Cellular
Systems Modelling Database and can be accessed at http://jjj.bio.vu.nl/database/penkler. The
investigation and complete experimental data set is available on EuroSEEK
(doi: 10.15490/seek.1.investigation.56)
2 Abbreviations
enzymes: ALD, fructose-bisphosphate aldolase (EC 4.1.2.13); GAPDH, glyceraldehyde-
3-phosphate dehydrogenase (phosphorylating) (EC 1.2.1.12); GLYDH, glycerol-3-
phosphate dehydrogenase (EC 1.1.99.5); HK, hexokinase (EC 2.7.1.1); PGI, glucose-
6-phosphate isomerase (EC 5.3.1.9); LDH, lactate dehydrogenase (EC 1.1.1.27);
PFK, 6-phosphofructokinase (EC 2.7.1.11); PGK, phosphoglycerate kinase (EC
2.7.2.3); PGM, phosphoglycerate mutase (EC 5.4.2.12); ENO, phosphopyruvate
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hydratase (EC 4.2.1.11); PK, pyruvate kinase (EC 2.7.1.40); TPI, triose-phosphate
isomerase (EC 5.3.1.1).
intermediates: G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; F16BP, fruc-
tose 1,6-bisphosphate; DHAP, glycerone phosphate; G3P, glycerol 3-phosphate;
GAP, d-glyceraldehyde 3-phosphate; B13PG, 1,3-bisphosphoglycerate;
3PG, 3-phosphoglycerate; 2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate;
PYR pyruvate; LAC lactate; GLC glucose.
3 Introduction
Despite several attempts at a complete eradication of the disease, malaria is still killing more
than half a million people per year, mostly small children in sub-saharan Africa (World Health
Organisation report 2013). The disease is caused by parasitic protozoa of the Plasmodium genus,
which have a complicated life cycle consisting of an insect vector and vertebrate host (for a recent
review see [1]). In the human host, parasite sporozoites first invade liver cells, but the malaria
disease symptoms manifest only at a later stage during multiplication of the asexual stages of
the parasite in red blood cells (RBCs). The blood life-cycle consists of ring, trophozoite and
schizont stages and after RBC lysis leads to the formation of merozoites, which can further infect
RBCs, or differentiate to sexual gametocytes, which invade the insect vector upon a mosquito
bite.
The aetiology of the disease is not well-understood, but the best predictors for poor chances of
survival, hypoglycaemia and lactic acidosis, are directly linked to glucose (GLC) metabolism in
the infected host [2], although it is not known to what extent the glycolytic activity of the parasite
contributes to this. With the ultimate aim to deeply understand changes in GLC metabolism
during malaria infection and to identify potential drug targets in the parasite, we have started
a detailed study in central carbon metabolism of Plasmodium falciparum. Our strategy is to
use a hierarchical modelling approach, starting with modelling of the Plasmodium trophozoite
stage, then linking the parasite model with a red blood cell model for glucose metabolism [3, 4],
and extending to the other blood stages of the parasite, including bursting and reinvasion of
erythrocytes. We will have separate construction and validation data sets for each of these stages.
Ultimately these hierarchies will include whole body glucose metabolism during Plasmodium
infection, first in animal models and eventually for human malaria patients. By comparing the
parasite with human cell models a differential control analysis approach will be used to identify
potential drug targets [5].
Central carbon metabolism of P. falciparum consists of glycolysis and the pentose phosphate
pathway. The parasite is dependent on glycolysis for ATP production [6] and does not store any
reduced carbon reserves [7, 8]. Although a modified form of the tricarboxylic acid (TCA) cycle
exists, it is not directly linked to glycolysis due to localisation of the pyruvate dehydrogenase
complex in the apicoplast. Instead, the TCA cycle utilises primarily glutamine and glutamate
as its carbon sources [9]. It was initially thought that P. falciparum glycolysis was homolactic,
which was supported by the finding of an almost 2:1 ratio of lactate (LAC) produced per GLC
consumed [8]. However, this is inconsistent with several reports of pyruvate (PYR) and glycerol
(GLY) production [10, 11]. The pentose phosphate pathway flux is low in asexual P. falciparum
[8, 12] and for this study we focused on the enzymes of the classic Embden-Meyerhof-Parnas
pathway, including GLY production and transport reactions (see Fig. 1).
Most of the glycolytic enzymes have been kinetically characterised for a variety of Plasmodium
species, often as pure enzymes (after cloning, expression and isolation), under conditions optimal
for the respective enzymes. Despite the multitude of reports on kinetics of individual enzymes
2
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Figure 1: Glycolysis and metabolite transport reactions in P. falciparum as included in the
kinetic model.
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of the glycolytic pathway of Plasmodium, to the best of our knowledge no study has been
published on an integrated analysis of the enzyme kinetics. Ideally, for such an integrated
analysis the kinetic parameters should be determined under physiologically relevant conditions
[13]. Typically, for integration of enzyme kinetics a mathematical model would be constructed,
which can be validated by its predictive strength of (non-fitted) complete system data-sets,
a process described in the Silicon Cell initiative [14]. Many mathematical models have been
constructed for central carbon metabolism in a number of organisms (for examples of glycolytic
models see [4, 15, 16]).
Different types of rate equations are used for mathematical modelling of enzyme reaction net-
works. These range from simple rate equations (e.g. mass action kinetics and lin-log kinetics
[17]) to very detailed rate equations (e.g. kinetics defined in terms of elementary rate constants
[3]). Whereas the simple rate equations have the advantage that they contain few parameters,
they are often limited in their applicability to a narrow range around a steady state reference
state. The detailed rate equations give a close representation of the enzyme kinetic mechanism,
but have many kinetic parameters, which are often difficult to quantify. For modelling stud-
ies of reaction networks an interesting in-between level of detail for rate equations has been
suggested in the form of “convenience kinetics” [18], and as generic rate equations [19]. The
generic rate equations have a mechanistic basis, i.e. they can be derived assuming a random-
order equilibrium-binding mechanism, but have been shown to be able to capture the kinetic
behaviour of various other enzyme kinetic mechanisms [19]. In mathematical models it is im-
portant to chose a correct level of detail to describe a system, and generic rate equations with
operationally defined parameters, have been shown to be adequate for many modelling studies
focussing on steady state behaviour of reaction networks.
In this study we test whether the integrated kinetics of the glycolytic enzymes of P. falciparum
can predict steady state pathway fluxes and metabolite concentrations in the intact trophozoite
blood stage form. We first present the biochemical characterisation of each of the glycolytic
enzymes and fit the kinetic behaviour with generic kinetic equations, based on random-order
equilibrium-binding mechanisms. The equations are then integrated in an ordinary differential
equations (ODEs) based model. The steady state of the kinetic model is analysed and compared
to experimental fluxes and metabolite concentrations that were obtained with intact P. falci-
parum cells. The complete workflow, including data sets and model files are made available in
the SEEK data and model management platform [20], making the modelling process completely
transparent and reproducible.
4 Results and Discussion
4.1 Kinetic characterization
We used a bottom-up systems biology approach for the construction of a detailed kinetic model
of glycolysis in the malaria parasite P. falciparum, to test whether the in vitro enzyme kinetics
can be used to predict in vivo steady state behaviour. In this section we present the kinetic char-
acterization for each of the glycolytic enzymes, including the parameterisation of rate equations
and comparison to literature values of parameters (if available). The enzyme kinetic experiments
were performed in cell free extracts, and activities are expressed in units per mg total protein.
We use generic rate equations, based on equilibrium binding, random order mechanisms, for the
description of the enzyme kinetic experiments. These mechanisms do not necessarily reflect the
real enzyme kinetic mechanism but the rate equations can describe the kinetic data well, and
have operationally defined parameters with an unambiguous interpretation. For special cases,
such as enzymes subject to substrate inhibition, we have derived additional rate equations and
4
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give the assumptions for the derivation in the text.
For this study we focus on the trophozoite stage of Plasmodium falciparum and on a single
physiological reference state of pH 7.2 and a temperature of 37◦C. In section 4.2 we present the
specific activity data for the glycolytic enzymes as measured in cell extracts of P. falciparum
trophozoites. In section 4.3 we give details on the model construction and finally in section
4.4 we compare model predictions with experimental flux and metabolite values obtained with
intact trophozoites.
4.1.1 Hexokinase
Hexokinase (HK) catalyses the ATP dependent phosphorylation of GLC to glucose 6-phosphate
(G6P) and ADP. The enzyme showed hyperbolic saturation kinetics for GLC, and the product
inhibition by G6P and ADP followed monotonous trends, while ATP displayed substrate inhi-
bition (Fig. 2) which became very pronounced at concentrations above 5 mM. For fitting of the
enzyme kinetic parameters, we only took the experimental data for ATP concentrations up to 5
mM into account, considering any higher concentrations as non-physiological. For HK and all
other kinases we assumed that Mg-ATP is the active ATP complex, and since Mg2+ was always
maintained at least at twice the concentration of ATP we assumed all ATP in the assays in the
Mg-ATP form.
vHK =
VfHK · atpKATP ·
glcin
KGLCin
·
(
1− adp·g6patp·glcin·Keq
)
(
1 + adpKADP +
atp
KATP
)
·
(
1 + g6pKG6P +
glcin
KGLCin
)
· (1 + atpKiATP )
(1)
For the fitting of the kinetic data we used Eqn 1, derived assuming a random order bi-bi
mechanism with equilibrium binding of substrates, products and effectors. In this and sub-
sequent equations we use the following symbols: Vx maximal rate of enzyme x, expressed in
(µmol·min−1·mg−1 total protein), Kx dissociation constant of x in mM, Kix inhibitor disso-
ciation constant in mM, and Keq equilibrium constant. The lower case abbreviations denote
concentrations (e.g. atp=[ATP]). These notations will be used throughout the manuscript. The
kinetic mechanism of ATP inhibition is not known and we assumed that ATP can bind to each
of the enzyme complexes. This equation could describe the kinetics quite well (Fig. 2), although
the dissociation constants for GLC and ATP are lower than the KM values determined by Roth
et al. [21]. In [21] no kinetic data or rate equations are given, and the reported KM value for
ATP is measured in infected erythrocyte lysates and thus reflects a combination of parasite and
Table 1: Kinetic parameters for P. falciparum hexokinase. The parameter values (± asymptotic
standard error) were obtained by fitting Eqn. 1 to the normalised combined HK data set (Fig.
2). Literature values are given for HK as determined in P. falciparum infected erythrocyte
lysates [21]. The maximal specific activity, VfHK was determined independently in cell extracts
and is expressed per mg total protein (see Fig. 15).
Parameter Fitted Value Literature Value Reference
VfHK (µmol·min−1·mg−1) 0.39 ± 0.09 -
KGLC (mM) 0.17 ± 0.02 0.43 ± 0.02 [21]
KATP (mM) 0.70 ± 0.03 3 ± 1 [21]
KiATP (mM) 26 ± 5 - -
KADP (mM) 0.8 ± 0.1 - -
KG6P (mM) 0.04 ± 0.01 - -
Keq 1310 [22]
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erythrocyte HK kinetics, although predominantly determined by parasite kinetics (erythrocyte
hexokinase: KMATP (mM) = 2.5 ± 1.0 [21] and KMGlc (mM) = 0.098 ± 0.0010 [21]). One must
be careful to compare kinetic constants that were determined for different rate equations as they
might not have the same mechanistic interpretation.
4.1.2 Phosphoglucoisomerase
Phosphoglucoisomerase (PGI) catalyses the conversion of G6P to fructose 6-phosphate (F6P).
Hyperbolic saturation kinetics were obtained for both G6P and F6P and a reversible Michaelis-
Menten equation (Eqn. 2) fitted the combined data set well (Fig. 3). The parameter values for
the fit are listed in Table 2. For the model we expressed VrPGI in the rate equation as a function
of VfPGI , KG6P , KF6P and Keq using the Haldane equation with a Keq value of 0.33 [23, 24].
vPGI =
VfPGI · g6pKG6P − VrPGI ·
f6p
KF6P
1 + f6pKF6P +
g6p
KG6P
(2)
Table 2: Kinetic parameters for P. falciparum PGI. Eqn 2 was fitted to the normalised com-
bined PGI data and the fitted parameters are indicated with asymptotic standard error. The
forward and reverse maximal specific activities (VfPGI and VrPGI ) were determined in separate
experiments in cell extracts and are expressed per mg total protein (Fig. 15). Keq value was
calculated with the Haldane relation.
Parameter Fitted Value Literature Value Reference
VfPGI (µmol·min−1·mg−1) 3.7 ± 0.2 - -
VrPGI (µmol·min−1·mg−1) 1.4 ± 0.3 - -
KG6P (mM) 1.0 ± 0.1 - -
KF6P (mM) 0.10 ± 0.01 0.26 ± 0.03 [25]
Keq 0.3 ± 0.1 0.33 [23, 24]
Srivastava et al. identified and characterised three PGI isoenzymes of P. falciparum each with
a similar KM for fructose 6-phosphate [25], for which the average value and SEM are given in
Table 2. The expression profile of the three isozymes during the asexual development phase
of the P. falciparum life cycle is not known and in our model we simulate PGI activity as an
average activity of the three isozymes.
4.1.3 Phosphofructokinase
PFK catalyses the ATP-dependent phosphorylation of F6P to fructose 1,6-bisphosphate (F16BP).
The enzyme showed hyperbolic saturation kinetics for F6P and monotonous curves for the inhi-
bition by F16BP and ADP but displayed substrate inhibition for ATP (Fig. 4). ATP inhibition
was also observed for PFK of P. berghei [26–29], but we did not observe regulation by PEP and
F16BP in P. falciparum, which is in agreement with [30]. In Fig. 4 the specific activities were
normalised to a control rate determined with 1.25 mM ATP and 10 mM F6P.
We fitted an irreversible, random order binding mechanism with substrate inhibition for ATP,
assuming that ATP can bind to all enzyme forms (see Eqn. 3).
vPFK =
VPFK · atpKATP ·
f6p
KF6P
(1 + atpKiATP ) · (1 +
f6p
KF6P
+ f16bpKF16BP ) · (1 +
atp
KATP
+ adpKADP )
(3)
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Figure 2: Kinetic characterisation of P. falciparum hexokinase. Panel A, saturation of HK with
GLC (0.5 mM ATP, squares and dashed line; 1.25 mM ATP, circles and solid line). Panel B,
saturation with ATP (10 mM GLC). Panel C, inhibition by G6P (10 mM GLC and 1.25 mM
ATP). Panel D inhibition by ADP (1.25 mM ATP and 10 mM GLC, squares and solid line;
0.625 mM ATP and 3.125 mM GLC, circles and dashed line). Eqn 1 was fitted to the complete
dataset, equation fits (lines) and 90% mean prediction confidence intervals (shaded areas) are
indicated, (fitted parameters values are presented in Table 1). Specific activities are normalised
to VfHK . The error bars represent SEM of technical triplicates, with the number of independent
experiments: 3, 4, 3, 2 for panels A, B, C and D respectively.
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Figure 3: Kinetic characterisation of P. falciparum phosphoglucoisomerase. The fit to Eqn 2
and the 90% mean prediction confidence intervals (shaded areas) are shown for the saturation
kinetics of PGI with G6P (A) and F6P (B). The data comprise five independent experiments
(two for the forward reaction and three for the reverse reaction). Error bars represent SEM of
technical triplicates. Specific activities are normalised to VfPGI .
When fitting Eqn. 3 to the experimental data set we observed that KATP and KiATP had
similar values and could not be estimated independently. We therefore set the values of the two
constants as equal.
Table 3: Summary of kinetic parameter values for P. falciparum phosphofructokinase. The
parameters (± asymptotic standard error) were obtained by fitting Eqn. 3 to the combined
kinetic data set (Fig. 4). VfPFK was calculated from the specific activity (measured in cell
extracts and expressed per mg total protein) and Eqn. 3, see Fig. 15 and Section 4.2.
Parameter Fitted Value
VfPFK (µmol·min−1·mg−1) 1.9 1± 0.3
KATP (mM) 0.79 ± 0.04
KF6P (mM) 1.07 ± 0.06
KF16BP (mM) 3.6 ± 0.5
KADP (mM) 0.7 ± 0.1
1 Note that this value is highly dependent on the specific rate equation used.
4.1.4 Aldolase
Aldolase catalyses the aldol cleavage of F16BP into GAP and DHAP. The forward reaction for
P. falciparum aldolase was characterised for its substrate, F16BP (Fig 5), for which it displayed
a high affinity, which is in agreement with earlier findings [31], although our KF16BP value
was higher (see Table 4). Since we use enzyme linked assays we could not analyse product
inhibition for the forward reaction, and neither could we analyse the reverse reaction due to
8
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Figure 4: Kinetic characterisation of P. falciparum phosphofructokinase. The enzyme was
characterised in terms of its substrates: Panel A, F6P (with 1.25 mM ATP) and Panel B, ATP
(with 0.25 mM F6P, triangles and dotted line; 0.5 mM F6P, diamonds and dot-dashed line; 1
mM F6P, squares and dashed line; 10 mM F6P, circles and solid line) as well as its products,
Panel C, F16BP (with 10 mM F6P and 1.25 mM ATP) and Panel D, ADP (with 0.3125 mM
ATP, and varying F6P concentrations: 0.25 mM, triangles and dotted line; 0.5 mM diamonds
and dot-dashed line; 1 mM squares and dashed line; 10 mM circles and solid line). Eqn. 3 was
fitted simultaneously to the complete dataset, equation fits (lines) and 90% mean prediction
confidence intervals (shaded areas) are indicated and fitted parameters values are presented in
Table 3. The data are a combination of 8 independent experiments and error bars represent SEM
(n >3). Specific activities are normalised to a control rate VcPFK , see Materials and Methods for
assay conditions.
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Figure 5: Kinetic characterisation of P. falciparum aldolase. Saturation kinetics of ALD with
F16BP was fitted to Eqn 4 and the fit and 90% mean prediction confidence intervals (shaded
areas) are shown. The data are a combination of two independent experiments. Error bars
represent SEM of technical triplicates. Specific activities are normalised to VfALD .
the absence of good linking reactions. The dissociation constants for the products, KGAP and
KDHAP were estimated by averaging the values published for T. brucei, Lactococcus lactis and
human erythrocytes [32–34], listed in Table 4. The kinetic data were described by a random
order uni-bi mechanism (Eqn. 4), and the parameters are summarised in Table 4.
vALD =
VfALD · f16bpKF16BP ·
(
1− dhap·gapKeq·f16bp
)
1 + dhapKDHAP +
f16bp
KF16BP
+ gapKGAP +
dhap·gap
KDHAP·KGAP
(4)
Table 4: Kinetic parameters for P. falciparum ALD. Eqn 4 was fitted to the normalised combined
ALD data and the fitted parameters are indicated with asymptotic standard error. The maximal
specific activity, VfALD was determined in separate experiments in cell extracts and is expressed
per mg total protein (Fig. 15).
Parameter Fitted Value Literature Value Reference
VfALD (µmol·min−1·mg−1) 0.27 ± 0.01 -
KF16BP (mM) 0.068 ± 0.004 0.025 ± 0.006 [31]
KGAP (mM) - 0.05 ± 0.021 [32–34]
KDHAP (mM) - 0.11 ± 0.091 [32–34]
Keq (mM−1) - 0.090 [35]
1 Average value of affinities in T. brucei, L. lactis and human erythrocytes (Mean ± SEM).
4.1.5 Triosephosphate Isomerase
Triosephosphate isomerase (TPI) catalyses the isomerisation of DHAP and GAP. Hyperbolic
saturation kinetics were obtained for DHAP and GAP, and for the inhibition by PEP. We used
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a reversible Michaelis-Menten equation with a competitive inhibitor (Eqn. 5) to fit the kinetic
data (Fig. 6). The fitted parameters for the equation are shown in Table 5. The binding
constant for GAP is in good agreement with the literature but we measured a lower affinity
for DHAP [36, 37]. The inhibition of TPI with PEP has not been described for P. falciparum
but has been observed in a number of organisms [38, 39] and binding of PEP was shown to be
competitive to DHAP and GAP [40].
vTPI =
VfTPI · dhapKDHAP − VrTPI ·
gap
KGAP
1 + dhapKDHAP +
gap
KGAP
+ pepKiPEP
(5)
Table 5: Kinetic parameters for P. falciparum TPI. Eqn 5 was fitted to the normalised com-
bined TPI data and the fitted parameters are indicated with asymptotic standard error. The
forward and reverse maximal specific activities (VfTPI and VrTPI ) were determined in separate
experiments in cell extracts and are expressed per mg total protein (Fig. 15). Keq value was
calculated with the Haldane relation.
Parameter Fitted Value Literature Value Reference
VfTPI (µmol·min−1·mg−1) 7 ± 1 - -
VrTPI (µmol·min−1·mg−1) 15 ± 1 - -
KGAP (mM) 0.34 ± 0.04 0.4 ± 0.2 [36, 37]
KDHAP (mM) 2.0 ± 0.3 0.59 [36]
KiPEP (mM) 0.016 ± 0.002 - -
Keq 0.08 ± 0.03 0.046 [41]
4.1.6 Glyceraldehyde-3-Phosphate Dehydrogenase
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyses the conversion of GAP, Pi and
NAD+ to 1,3-bisphosphoglycerate (B13PG) and NADH. The enzyme showed hyperbolic satu-
ration kinetics for all reactants and products (Fig. 7). Pi kinetics were not analyzed and a
concentration of 10 mM was used in the assays. The Keq calculated with the Haldane equation
is in reasonable agreement with the literature value adjusted for pH = 7.2 (Table 6).
vGAPDH =
VfGAPDH·
gap·nad
KGAP· KNAD − VrGAPDH·
nadh·b13pg
KNADH·KB13PG(
1 + nadKNAD +
nadh
KNADH
) (
1 + gapKGAP +
b13pg
KB13PG
) (6)
For fitting of the kinetic data we used Eqn 6, which was derived assuming a random ordered
bi-bi mechanism and could describe the experimental data well (Fig. 7). The fitted parameters
are summarised in Table 6.
For the B13PG saturation kinetics we produced B13PG in a linked PGK assay which was
assumed to be in equilibrium (see Materials and Methods). GAPDH of P. falciparum has not
been extensively characterised before, but the binding constant for GAP is in good agreement
with the literature [42].
4.1.7 Phosphoglycerate kinase
Phosphoglycerate kinase (PGK) catalyses the conversion of B13PG to 3-phosphoglycerate (3PG)
with substrate level phosphorylation of ADP to ATP. The P. falciparum PGK was characterised
11
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Figure 6: Kinetic characterisation of P. falciparum TPI. Saturation kinetics of the enzyme is
shown in Panel A for DHAP, in Panel B for GAP. In Panel C the inhibition by PEP (vTPI
measured in reverse direction with 10 mM GAP) is shown. The combined data set was fitted to
Eqn 5 and the fit and 90% mean prediction confidence intervals (shaded areas) are indicated.
The data are a combination of two independent experiments. Error bars represent SEM of
technical replicates (n=6). Specific activities are normalised to VfTPI or VrTPI for the forward or
reverse rates respectively.
in the reverse direction, with saturation curves for ATP and 3PG, and inhibition by ADP (Fig.
8). For the binding constant of B13PG (KB13PG) we used a literature value of 0.013 mM [44].
The kinetic data (Fig. 8) were described by a random order bi-bi mechanism (Eqn. 7) with
12
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Figure 7: Kinetic characterisation of P. falciparum GAPDH. Saturation of the enzyme is shown
in Panel A for GAP (5 mM NAD) and in Panel B for NAD+ (20 mM GAP) in the forward direc-
tion and in Panel C for B13PG (0.8 mM NADH) and in Panel D for NADH (0.12 mM B13PG)
in the reverse direction. Eqn 6 was fitted to the complete dataset, fits and 90% mean prediction
confidence intervals (shaded areas) are shown, (fitted parameters values are presented in Table
6). The error bars represent SEM of technical triplicates of 2 independent experiments. B13PG
is not commercially available and we calculated equilibrium concentrations for B13PG produced
in a linked assay with saturating concentrations of PGK. Specific activities are normalised to
VfGAPDH or VrGAPDH for the forward or reverse rates respectively.
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Table 6: Kinetic parameters for P. falciparum GAPDH. Eqn 6 was fitted to the normalised
combined GAPDH data and the fitted parameters are indicated with asymptotic standard error.
The forward and reverse maximal specific activities (VfGAPDH and VrGAPDH ) were determined
in separate experiments in cell extracts and are expressed per mg total protein (Fig. 15). Keq
was calculated for 10 mM phosphate concentration and a pH of 7.2.
Parameter Fitted Value Literature Value Reference
VfGAPDH (µmol·min−1·mg−1) 3.1 ± 0.2 - -
VrGAPDH (µmol·min−1·mg−1) 1.2 ± 0.3 - -
KGAP (mM) 0.9 ± 0.1 1.0 [42]
KB13PG (mM) 0.024 ± 0.002 - -
KNAD (mM) 0.57 ± 0.06 - -
KNADH (mM) 0.029 ± 0.004 - -
Keq (mM) 0.0035 0.0089 [43]
Table 7: Kinetic parameters for P. falciparum PGK. Eqn 7 was fitted to the normalised combined
PGK data and the fitted parameters are indicated with asymptotic standard error. The reverse
maximal specific activity VrPGK was measured in separate experiments in cell extracts and is
expressed per mg total protein. VfPGK was calculated using the Haldane relationship.
Parameter Fitted Value Literature Value Reference
VrPGK (µmol·min−1·mg−1) 1.7 ± 0.2 -
VfPGK (µmol·min−1·mg−1) 30 -
KADP (mM) 0.15 ± 0.01 0.301 [44]
KATP (mM) 0.77 ± 0.05 0.681, 0.632 [44], [45]
K3PG (mM) 0.27 ± 0.02 0.171, 0.522 [44], [45]
KB13PG (mM) - 0.0131 [44]
Keq - 3200 [46]
1 Determined for PGK-deficient erythrocytes infected with P. falciparum.
2 Determined for recombinant P. falciparum PGK.
fitted parameters as given in Table 7.
vPGK =
VrPGK · 3pg·atpK3PG·KATP ·
(
adp·b13pg·Keq
atp·3pg − 1
)
(
1 + adpKADP +
atp
KATP
) (
1 + b13pgKB13PG +
3pg
K3PG
) (7)
Since we measured the PGK in reverse direction we have expressed the VfPGK in terms of VrPGK ,
the dissociation constants and Keq as derived from the Haldane relation.
Two isoenzymes of PGK have been isolated from P. falciparum [8], but the role of these isoen-
zymes and their expression profiles during the different life stages are not known. The kinetic
parameters determined here are weighed averages of both isoenzymes. The kinetic parameters
determined by us are in fair agreement with published values, although we obtained a higher
affinity for ADP.
4.1.8 Phosphoglycerate Mutase
Phosphoglycerate mutase (PGM) catalyses the conversion of 3PG to 2PG. Hyperbolic saturation
kinetics were obtained for 3PG and 2PG. We used a reversible Michaelis-Menten equation (Eqn.
14
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Figure 8: Kinetic characterisation of P. falciparum PGK. The reaction was measured in the
reverse direction, and saturation of the enzyme with ATP (A, 5 mM 3PG) and 3PG (B, 4 mM
ATP) and inhibition by ADP (C, 4 mM 3PG, and 3 mM ATP) is shown. Eqn 7 was fitted to the
complete dataset, fits and 90% mean prediction confidence intervals (shaded areas) are shown,
(fitted parameters values are presented in Table 7). The error bars represent SEM of technical
triplicates, of 2 independent experiments. The specific activities are normalised to VrPGK .
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Figure 9: Kinetic characterisation of P. falciparum PGM. Saturation kinetics of the enzyme
with 3PG (A) and 2PG (B) was fitted to Eqn 8 and the fit and 90% mean prediction confidence
intervals (shaded areas) are shown. The data are a combination of two independent experiments.
Error bars represent SEM of technical triplicates. The specific activities are normalised to VfPGM
or VrPGM for the forward or reverse rates respectively.
8) to fit the kinetic data. The parameterised rate equation described the data set well (Fig. 9),
although our binding constants were higher than published values (Table 8).
vPGM =
VfPGM · 3pgK3PG − VrPGM ·
2pg
K2PG
1 + 2pgK2PG +
3pg
K3PG
(8)
4.1.9 Enolase
Enolase (ENO) catalyses the conversion of 2PG to phosphoenolpyruvate (PEP). Hyperbolic
saturation kinetics were obtained for 2PG and PEP. A reversible Michaelis-Menten equation
(Eqn. 9) was fitted to the kinetic data (Fig. 10), resulting in the parameters given in Table 9.
Table 8: Kinetic parameters for P. falciparum PGM. Eqn 8 was fitted to the normalised com-
bined PGM data and the fitted parameters are indicated with asymptotic standard error. The
forward and reverse maximal specific activities (VfPGM and VrPGM ) were determined in separate
experiments in cell extracts and are expressed per mg total protein (Fig. 15).
Parameter Fitted Value Literature Value Reference
VfPGM (µmol·min−1·mg−1) 0.87 ± 0.09 - -
VrPGM (µmol·min−1·mg−1) 0.4 ± 0.1 - -
K3PG (mM) 1.7 ± 0.1 0.85 [47]
K2PG (mM) 0.32 ± 0.02 0.041 [47]
Keq 0.14 - 0.451 0.10 [35]
1 Estimated with the Haldane relationship for the experimental error range of the parameters.
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Figure 10: Kinetic characterisation of P. falciparum ENO. Saturation kinetics of the enzyme
is shown in Panel A for 2PG and in Panel B for PEP. The data was fitted to Eqn 9 and
the fit and 90% mean prediction confidence intervals (shaded areas) are indicated. The data
are a combination of two independent experiments. Error bars represent SEM of technical
triplicates. The specific activities are normalised to VfENO or VrENO for the forward or reverse
rates respectively.
vENO =
VfENO
2pg
K2PG
− VrENO · pepKPEP
1 + 2pgK2PG +
pep
KPEP
(9)
The affinities for PEP and 2PG determined in this work are lower than determined by Pal-
Bhowmick et al., (see Table 9), for recombinantly expressed purified enzyme [48]. Although
these literature values were determined at optimal pH for the enzyme (7.4) and 20 oC, while we
measured at physiological temperature and pH values (37 oC and 7.2), it is unlikely that these
relatively small differences in conditions would cause a significant effect on the affinity of ENO
for 2PG and PEP.
Table 9: Kinetic parameters for P. falciparum ENO. Eqn 9 was fitted to the normalised com-
bined ENO data and the fitted parameters are indicated with asymptotic standard error. The
forward and reverse maximal specific activities (VfENO and VrENO) were determined in separate
experiments in cell extracts and are expressed per mg total protein (Fig. 15).
Parameter Fitted Value Literature Value Reference
VfENO (µmol·min−1·mg−1) 1.3 ± 0.4 - -
VrENO (µmol·min−1·mg−1) 0.9 ± 0.4 - -
K2PG (mM) 0.52 ± 0.04 0.041 ± 0.004 [48]
KPEP (mM) 1.3 ± 0.1 0.25 ± 0.03 [48]
Keq 1.8 - 9.61 4.6 [35]
1 Estimated with the Haldane relationship for the experimental error range of the parameters.
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4.1.10 Pyruvate Kinase
Pyruvate kinase (PK) catalyses the conversion of PEP to pyruvate (PYR) with substrate level
phosphorylation of ADP to ATP. The P. falciparum PK was characterised in the forward di-
rection, with saturation curves for PEP and ADP, and inhibition by PYR and ATP. From the
saturation curves (Fig. 11) it is apparent that the PK is under kinetic regulation, inhibited by
both of its substrates at higher concentrations and inhibited cooperatively by its product ATP.
We used a random order bi-bi irreversible Monod-Wyman-Changeux rate equation to model
the PK reaction. It was assumed that the R and T conformations have equal affinities for the
substrates ADP and PEP, but that neither conformation binds the products ATP and PYR to
an appreciable extent at the active site. Finally, two additional independent allosteric sites exist
for the ADP/ATP pair and the PEP/PYR pair to which they bind with infinite cooperativity
(all-or-none). The enzyme is assumed to be tetrameric (n=4). These assumptions yield Eqn. 10
that could describe the kinetic data well (Fig. 11), with fitted parameters as given in Table 10.
vPK =
VfPK · adpKADP · pepKPEP · (1 + adpKADP )n−1 · (1 + pepKPEP )n−1
(1 + adpKADP )
n · (1 + pepKPEP )n
 · ( 11 + L
)
(10)
L = L0
(
1 +
( adp
KiADP
+ atp
KiATP
)n)
·
(
1 +
( pyr
KiPYR
+ pep
KiPEP
)n)
Table 10: Kinetic parameters for P. falciparum PK. Eqn 10 was fitted to the normalised com-
bined PK data and the fitted parameters are indicated with asymptotic standard error. The
forward maximal specific activities (VfPK was determined in separate experiments in cell extracts
and is expressed per mg total protein, Fig. 15).
Parameter Fitted Value Literature Reference
VfPK (µmol·min−1·mg−1) 3.6 ± 0.2
KADP (mM) 0.32 ± 0.05 0.13 ± 0.04 [49]
KPEP (mM) 0.41 ± 0.05 0.19 ± 0.03 [49]
KiPyr (mM) 105 ± 12 - -
KiATP (mM) 1.8 ± 0.2 - -
KiADP (mM) 2.0 ± 0.2 - -
KiPEP (mM) 2.9 ± 0.2 - -
L0 0.26 ± 0.11 - -
n 4
P. falciparum possesses two homotetrameric pyruvate kinases (PK1 and PK2). Both are ex-
pressed during the asexual phase [50], but PK1 expression is constant and continually high
throughout the asexual phase and thought to be part of glycolysis, whereas PK2 correlates
with the expression of lipid synthesis genes. Since the enzyme characterisation is in tropho-
zoite lysates, both isozymes would be present and the kinetic parameters determined here would
therefore be weighed averages of both isoenzymes, where it is to be expected that PK1 has a
much stronger contribution than PK2 [50]. Chan et al., [49] reported higher affinities for ADP
and PEP than were determined by us but it is hard to compare the values as they are dependent
on the experimental conditions and the kinetic mechanism assumed for their determination.
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Figure 11: Kinetic characterisation of P. falciparum PK. Saturation kinetics of the enzyme is
shown in Panel A for PEP (with ADP = 0.156, 0.613 and 2.5 mM respectively for the solid,
dashed and dash-dotted lines) and in Panel B for ADP (with 5 mM PEP). Inhibition of the
PK is shown in Panel C for PYR (with 1.25 mM PEP and 1.0 mM ADP) and in Panel D
for ATP (with 0.625 mM PEP and 0.625 mM ADP). The combined data set was fitted to
Eqn 10 and the fit and 90% mean prediction confidence intervals (shaded areas) are indicated.
The data are a combination of seven independent experiments. Error bars represent SEM of
technical triplicates. The specific activities are normalised to a control rate VcPK , see Materials
and Methods for PK assay conditions.
19
Stellenbosch University  https://scholar.sun.ac.za
4.1.11 Lactate Dehydrogenase
P. falciparum lactate dehydrogenase (LDH) reduces PYR to lactate (LAC) with the concomitant
oxidation of NADH to NAD+. The enzyme was characterised in the forward and reverse direction
(Fig. 12). Pyruvate has been shown to inhibit the enzyme at high concentrations with a Ki
of 140 mM [51], but this inhibition is negligible at physiological concentrations of pyruvate and
thus excluded. The combined kinetic data were described successfully (Fig. 12) with a random
order bi-bi mechanism (Eqn. 11) and the fitted parameters are indicated in Table 11. These
parameter values are higher than the published values for purified LDH characterised under
optimal conditions for the enzyme [51, 52].
vLDH =
VfLDH·
nadh·pyr
KNADH·KPyr − VrLDH · lac·nadKLAC· KNAD(
1 + nadKNAD +
nadh
KNADH
) (
1 + lacKLAC +
pyr
KPYR
) (11)
We choose to use a generic rate equation, based on a random order binding mechanism for the
description of the LDH kinetics, even though the enzyme most likely follows an ordered bi-bi
mechanism. The most important reason for this was that the detailed ordered bi-bi mechanism
would introduce an additional four parameters (Ki values for each of the substrates and prod-
ucts), which would make the rate equation unnecessary complicated. We have shown before
that the kinetic behaviour of an ordered bi-bi mechanism can be described adequately with our
generic equation [19]. The dissociation constants that we obtained for PYR and NADH are
higher than those published for LDH before, while the K value for LAC is lower and the K value
for NAD is close to published values (see Table 11).
Table 11: Kinetic parameters for P. falciparum LDH. Eqn 11 was fitted to the normalised
combined LDH data and the fitted parameters are indicated with asymptotic standard error.
The forward and reverse maximal specific activities (VfLDH and VrLDH ) were determined in
separate experiments in cell extracts and are expressed per mg total protein (Fig. 15).
Parameter Fitted Value Literature Value Reference
VfLDH (µmol·min−1·mg−1) 2.5 ± 0.1 - -
VrLDH (µmol·min−1·mg−1) 1.4 ± 0.2 - -
KPyr (mM) 0.13 ± 0.01 0.030, 0.055 [51, 52]
KNADH (mM) 0.046 ± 0.003 0.0070, 0.011 [51, 52]
KLac (mM) 3.6 ± 0.3 12, 47 [51, 52]
KNAD (mM) 0.23 ± 0.02 0.086, 0.18 [51, 52]
Keq 150 - 4301 227 - 7194 [53, 54]
1 Estimated with the Haldane relationship for the experimental error range of the parameters.
4.1.12 Glycerol-3-phosphate dehydrogenase
Glycerol-3-phosphate dehydrogenase (G3PDH) reduces DHAP to glycerol 3-phosphate (G3P)
with the concomitant oxidation of NADH to NAD+. The enzyme activity was determined in the
forward direction and the saturation kinetics for DHAP and NADH, and the inhibition by G3P
and NAD+ are shown in Fig. 13. The reaction has a large equilibrium constant (Keq=32600) [55]
and we could not assay the enzyme in the reverse direction. A product sensitive, irreversible,
random order mechanism was used to derive a rate equation for the G3PDH activity (Eqn.
12). The rate equation was fitted to the combined data set for the estimation of the binding
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Figure 12: Kinetic characterisation of P. falciparum LDH. Saturation kinetics of the enzyme in
the forward direction is shown in Panel A for with NADH (with 1 mM PYR) and in Panel B
for PYR (with 0.8 mM NADH) and in the reverse direction in Panel C for NAD+ (with 20 mM
LAC) and in Panel D for LAC (with 2 mM NAD+). The complete data set was fitted to Eqn
11 and the fit and 90% mean prediction confidence intervals (shaded areas) indicated. The data
are a combination of three independent experiments. Error bars represent SEM of technical
triplicates. The specific activities are normalised to VfLDH or VrLDH for the forward or reverse
rates respectively.
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constants (Table. 12), the Vmax value was estimated from specific activity measurements in
separate experiments (Fig. 15).
vG3PDH =
VfG3PDH · dhap·nadhKDHAP·KNADH(
1 + nadKNAD +
nadh
KNADH
)
·
(
1 + g3pKG3P +
dhap
KDHAP
) (12)
Table 12: Kinetic parameters for P. falciparum G3PDH. Eqn. 12 was fitted to the normalised
combined G3PDH data and the fitted parameters are indicated with their asymptotic standard
error. The maximal specific activity, VfG3PDH , was obtained from separate experiments in cell
extracts and is expressed per mg total protein (Fig. 15).
Parameter Fitted Value Reference
VfG3PDH (µmol·min−1·mg−1) 0.06 ± 0.01
KDHAP (mM) 0.34 ± 0.04
KNADH (mM) 0.09 ± 0.01
KG3P (mM) 4 ± 2
KNAD (mM) 0.5 ± 0.1
Keq 32600 [55]
The production of glycerol (GLY) by asexual P. falciparum was reported by Lian et al. [11], but
there is still uncertainty about the exact metabolic route via which GLY is produced from G3P
[56]. The parasite possesses a glycerol kinase that was suggested to be active predominantly
in gametocytes [57], but a role in the a-sexual stages has been shown too [58]. However, the
enzyme is suggested to be mostly active in the phosphorylation of GLY to G3P and has not
been shown to be reversible. Furthermore, no putative genes for glycerol-3-phosphatase have
been identified in the P. falciparum genome [59]. However, there is a PGM isozyme, PGM2
[47], which has phosphatase activity and it may be able to utilise G3P as a substrate to produce
glycerol. The parasite does posses a aquaglyceroporin and transport of glycerol is probably fast
but kinetics in the parasite are not known [60].
Whereas we could detect G3PDH activity in cell extracts of P. falciparum, we could not detect
glycerol-3-phosphate kinase or phosphatase activity. We simulated the combined dephosphory-
lation and transport reactions with a single mass-action equation (Eqn. 13), with a kGLYtr of 1
min−1 assuming a rapid dephosphorylation of G3P and transport of GLY.
vGLYtr = kGLYtr · (g3p− glyex) (13)
4.1.13 Glucose transport
In P. falciparum GLC first crosses the parasitophorous vacuolar membrane via high-capacity
non-selective channels [61–63] after which it is transported across the parasite plasma membrane
via a saturable, sodium-independent and stereo-specific hexose transporter [64, 65]. Hexose
transporters have been characterised for several Plasmodium species [64–69], for P. falciparum
mostly after expressing the enzyme in Xenopus laevis oocytes. In these studies cells are typically
incubated for 5 to 20 minutes with GLC to determine uptake. It is hard to interpret GLC
transport studies in P. falciparum infected erythrocytes [61, 62] in terms of GLC transporter
kinetics of the isolated parasite. Saliba et al. [70] investigated the uptake of 2-deoxy-D-glucose
(2DOG) in isolated parasites but using incubation times greater than 20 s, which may not reflect
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Figure 13: Kinetic characterisation of P. falciparum G3PDH. Saturation kinetics of the enzyme
is shown in Panel A for DHAP (with 0.358 mM NADH) and in Panel B for NADH (with 5.55 mM
DHAP). Product inhibition of the enzyme is shown in Panel C for G3P (with 0.22 mM DHAP
and 0.358 mM NADH) and in Panel D for NAD+ (with 5.55 mM DHAP and 0.22 mM NADH).
The complete data set was fitted to Eqn 12 and the fit and 90% mean prediction confidence
intervals (shaded areas) are shown. The data are a combination of at least two independent
experiments. Error bars represent SEM of technical triplicates. The specific activities are
normalised to VfG3PDH .
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zero-trans influx kinetics. We studied GLC transport in isolated P. falciparum trophozoites using
short incubation times (0.2 to 20s) of 14C labelled D-GLC (Fig. 14 A).
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Figure 14: Kinetic characterisation of GLC transport in P. falciparum. A quench flow device
was used to study uptake of labelled D-GLC into isolated trophozoites. Intracellular 14C label
concentration was measured as a function of incubation time and normalised per time and
protein concentration (Panel A). The incubation time was varied between 0.2 and 20 s, and the
fitted line was used to estimate the specific uptake rate at zero seconds quench time. The data
are combined sets of four biological repeats. Error bars represent the mean ± SEM (n >2). In
Panel B, GLC transport as a function of GLC concentration was determined after 2 s incubation
time. Activities were normalised to the specific uptake rate at 2 s as determined in (A). Data
represent two independent experiments. To estimate the binding constant for GLC (KGLC), the
data were fitted to GLC transport rate equation, taking the internal GLC that has accumulated
after 2s into account. The fitted line was calculated with Eqn. 14 with parameter values as in
Table 13 taking the calculated internal GLC concentrations into account.
We used a quench flow device (see Materials and Methods) to measure uptake rates over a
range of incubation times (0.2 - 20 s), which allowed us to extrapolate uptake rates back to
a 0 s incubation time which reflect zero-trans influx kinetics. The calculated uptake rates
were normalised to total protein and are presented as the concentration increase in labelled
GLC divided by the time period of the incubation and plotted on a logarithmic scale for the
different incubation times in Fig. 14 A. The uptake rate of labelled GLC decreases strongly with
incubation time, already at very small quench times, clearly illustrating the effect of inhibition
of transport due to accumulation of internal GLC (Fig. 14 A). There is significant experimental
error in the determination of the GLC transport rate, which might reflect lysis of a fraction of
the cells during the washing step, and at short incubations times we operate the quench flow
device close to its dead-time period of 0.15 s. We estimated lower and upper boundaries for GLC
transport rates of 0.1, and 0.5 µmol/min/mg protein and a best fit value 0.21 µmol/min/mg
protein (Fig. 14 A), for the zero trans influx GLC transport rate at 5 mM GLC.
To measure GLC transport rates at the short quench times, high concentrations of biomass
and labelled GLC were needed and we had to work close to the dead-time of the quench flow
device. To study glucose saturation kinetics, we decided to work with a 2 s incubation time
and measured transport activities at different GLC concentrations (Fig. 14 B). Clearly at a
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2 s incubation time the internal GLC cannot be ignored, and to estimate the affinity of the
transporter we fitted Eqn. 14 to the experimental data, taking a 2 s integration of the activity
to calculate the internal GLC concentration into account. For the GLC transporter a reversible
kinetic equation was used (Eqn. 14) assuming a symmetrical transporter (i.e. KGLCin = KGLCex)
with an interactive constant α of 0.91 as determined for yeast [71].
vGLCtr = VfGLCtr · (glcex − glcin)
KGLC + glcex + glcin + α · glcin·glcexKGLC
(14)
Table 13: Summary of the kinetic parameters for P. falciparum hexose transport. The P.
falciparum hexose transporter has been characterised in terms of its maximal specific activity
and affinity for GLC. VfGLCtr was calculated from Fig. 14 (see text for details) and is expressed
per mg total protein.
Parameter Fitted Value Literature Value Reference
VfGLCtr (µmol·min−1·mg−1) 0.23 - -
KGLC (mM) 0.37 0.48, 1.0, 0.97 [64, 65, 68]
α - 0.91 [71]
In most kinetic analyses of GLC transport in P. falciparum the internal GLC concentration is
ignored when estimating the affinity for GLC (KGLC). Even in the short time incubations of
2s, as employed in our study there is already a significant build-up of internal GLC, inhibiting
GLC transport (see Fig. 14 A). Ignoring internal GLC in the analysis would lead to a significant
overestimation of the KGLC. If one would naively fit a Michaelis-Menten equation (i.e. assuming
the internal GLC concentration to be zero) to the data set in Fig. 14, this would give a Km
value of 1.8 mM, while we obtained a KGLC value of 0.37 mM with Eqn. 14, taking the
internal GLC into account. To calculate the internal glucose built up during the assay we
assumed that none of the transported glucose was further metabolised in the 2 s incubation. This
assumption leads probably to an overestimation of the internal GLC concentration. However,
since the trophozoites are kept on ice without energy source before the assay, the internal ATP
concentration is most likely very low, leading to a low HK activity. To test the effect of HK
activity on our estimation of KGLC, we simulated the accumulation of glucose during the 2
s uptake experiments with an active HK (eq 1), and a fixed ATP/ADP ratio of 5 and G6P
concentration of 1 mM (i.e. physiological conditions). The inclusion of HK in the analyses led
to a lower estimated KGLC of 0.23 mM. In our model we used the value of 0.37 mM as estimated
in the original analysis since this is closer to the estimated values in the literature.
4.1.14 Lactate and pyruvate transporters
LAC and PYR are secreted from the parasite into the RBC cytosol via a proton symport
transporter [10], which shares many characteristics of the monocarboxylate transporter (MCT)
family [72]. Elliot et al. [10] characterised the P. falciparum transporter for LAC and PYR
influx as a saturable H+ symport system with a 1:1 stoichiometry. They fitted the transporter
kinetics to Eqn. 15, where monocarboxylate refers to either LAC or PYR, and obtained values
for the Michaelis-Menten constant (Km) of 3.8 mM and 16 mM, and maximal specific activity
(Vmax) of 94 and 34 (mmol H+·min−1 ·L cell water−1) for LAC and PYR respectively. Eqn. 15
also contains a non-saturable component for which kd values of 0.80 and 0.11 min−1 were fitted
for LAC and PYR [10].
vMCT = Vmax · [monocarboxylate]
Km + [monocarboxylate]
+ kd · [monocarboxylate] (15)
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A couple of changes needed to be made to Eqn. 15 to be able to use it in our study. Firstly,
Elliot et al. varied monocarboxylate at a fixed pH gradient (pHout = 7.2 and pHin = 7.1)
and protons are not explicit in their rate equations, and secondly they assumed a zero trans-
influx transport of the monocarboxylate, i.e. internal concentration of the monocarboxylate
is assumed to be zero. These assumptions reduced their rate equation to a simple Michaelis-
Menten equation (with an additional non saturable component) for monocarboxylate transport
into the parasite. Under physiological conditions LAC and PYR are exported from the parasite
into the cytosol of the RBC, and we needed to adapt the rate equation to reflect a reversible
process, for which we needed to use an explicit pH gradient to correctly reflect the equilibrium
point where: [monocarboxylatein] · [H+in] = [monocarboxylateex] · [H+ex]. The intracellular pH
of P. falciparum strains has been shown to vary between 7.17 and 7.4 [73–77]. The average
pH was taken as 7.2 and the erythrocyte cytosolic pH set to 7.1 [74, 75, 77], which is close to
the pH value of the incubations used in the validation experiments. Lactate and pyruvate bind
competitively to the monocarboxylate transporter [78]. We assumed a symmetrical transporter,
with identical dissociation constants for internal and external LAC and PYR and equal maximal
rates for influx and eﬄux, leading to the following equations:
vLACtr =
VLACtr · lacinKLAC (1− 10
-pHex ·lacex
10-pHin ·lacin )
1 + lacinKLAC +
lacex
KLAC
+ pyrinKPYR +
pyrex
KPYR
+ kdLAC · lacin(1−
10-pHex · lacex
10-pHin · lacin ) (16)
vPYRtr =
VPYRtr · pyrinKPYR (1−
10-pHex ·pyrex
10-pHin ·pyrin )
1 + lacinKLAC +
lacex
KLAC
+ pyrinKPYR +
pyrex
KPYR
+ kdPY R · pyrin(1−
10-pHex · pyrex
10-pHin · pyrin
) (17)
In addition to changing the kinetic rate equations we also needed to adapt some of the parameter
values to convert to the correct units and experimental conditions. Using a cytosolic volume
of 4.67 µL cytosol·mg protein−1 (see Materials and Methods), the measured Vmax values for
lactate and pyruvate influx [10] were converted to 0.44 and 0.16 µmol·min−1 · mg protein−1
respectively for LAC and PYR. These rates were determined at an assay temperature of 4 ◦C,
and a much higher rate is expected at 37 ◦C. Using a temperature coefficient (Q10) value of 2 as
a rough estimator we assumed an 8 fold higher Vmax value for these transporters in our model.
A final, small correction was made to the values of Vmax and kd to include the directionality of
the process. Since we use the physiological direction (i.e. monocarboxylate eﬄux) as positive
direction we had to correct for the difference in pH accross the membrane. Note that Vmax and
kd as measured by Elliot et al. [10] include proton concentration implicitly. We scaled the kd
values to maintain the same relative activity to the Vmax values as at low temperature, resulting
in the following values used in the model: VPYRtr = 1.0 and VLACtr = 2.8 µmol·min−1 · mg
protein−1, kdLAC= 0.005, kdPY R = 0.0007 min−1, the binding constants for LAC and PYR were
not changed.
4.1.15 ATPase
ATP produced in glycolysis is used in a many different processes in the cell, and it is not possible
to experimentally characterise each of these reactions and to include each of them explicitly in
our model. Therefore, we define a single “ATPase” reaction, which is described by a Hill equation
(Eqn. 18). The intracellular ATP:ADP has been experimentally measured to be between 1 (GLC
starved) and 5.7 [73, 79–81]. We fitted VATPase (see Eqn. 18) to a steady state ATP:ADP ratio
of 5 giving a value of 1.75 µmol·min−1 · mg protein−1 and a KATP of 4.5 mM. We used a large
Hill coefficient of 5 to dynamically buffer the ATP:ADP ratio at 5, reflecting an energised state
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of the parasite.
vATPase =
VATPase · ( atpKATP )5
1 + ( atpKATP )
5 (18)
4.2 Maximal Specific Activities
In the preceding sections, specific enzyme activities were normalised to their Vmax values, i.e.
presented as (v/Vmax). Note that these Vmax values are extrapolated from specific activities
that were determined in cell extracts, and are expressed per mg total protein. Thus, these
Vmax values cannot be compared directly with Vmax values determined for purified enzymes,
since these are expressed per mg pure enzyme protein. Our Vmax values represent the maximal
specific activities of the enzymes in the extract and are dependent on the expression levels of
the enzymes.
A significant variation in specific activity of the glycolytic enzymes was observed between ex-
tracts and the normalisation of enzyme activity to its Vmax value, compensates for differences
in expression level of the enzymes and makes it possible to compare extracts prepared from dif-
ferent cultures. To get a good estimate of its variability, specific activities were determined for a
large number of different trophozoite isolations at saturating or near saturating concentrations
of substrate (Fig. 15). These specific activities were extrapolated to Vmax values by substituting
the substrate concentrations that were used in the activity assay into the respective rate equa-
tions. For the enzymes that exhibited substrate inhibition (i.e. PFK and PK), the Vmax value
could not be determined via extrapolation but needed to be solved from the rate equation. For
these enzymes we have given a control rate (Vc) determined under standard conditions in Fig.
15. The Vmax value for these enzymes were calculated from the respective rate equations and
are listed in the tables for the respective enzyme kinetic parameters.
4.3 Model Construction
The kinetic model for P. falciparum glycolysis consists of GLC transport into the parasite, 15
reactions in the parasite and 3 transport reactions for lactate, pyruvate and glycerol. The rate
equations and kinetic parameter values were given in the preceding sections, and form the core
of the mathematical model. A set of ordinary differential equations (ODEs) for the internal
metabolites can be defined in terms of these kinetic rate equations from the known reaction
network (Fig. 1).
27
Stellenbosch University  https://scholar.sun.ac.za
H
K
fw
d
P
G
Ifw
d
P
G
Ire
v
P
FK
fw
d
A
LD
fw
d
TP
Ire
v
TP
Ifw
d
G
A
P
D
H
fw
d
G
A
P
D
H
re
v
P
G
K
re
v
P
G
M
fw
d
P
G
M
re
v
E
N
O
fw
d
E
N
O
re
v
P
K
fw
d
LD
H
fw
d
LD
H
re
v
G
3P
D
H
0
1
2
3
4
V
m
ax
(m
ol
·(min
·mgp
ro
te
in
)-1 )
0.
38
7,
n=11
3.
74
1.
42
,n
=14
0.
43
9,
n=16
0.
26
6,
n=25
3.
06
,n
=4
1.
19
,n
=23 1.65,
n=24
0.
87
3,
n=22
0.
35
4,
n=3
1.
34
,n
=24
0.
93
5,
n=2
1.
42
,n
=30
2.
53
,n
=32
1.
36
,n
=7
0.
05
62
,n
=4
10
15
20
25
30
35
3.
74
,n
=17 15.,
n=3
7.
03
,n
=13
Figure 15: Comparison of the Vmax values of the P. falciparum glycolytic enzymes. The maximal
specific activities for each of the glycolytic enzymes of P. falciparum were determined from
numerous trophozoite isolations to ensure a good representation of the enzyme activities at
this stage of parasite development. The enzymes were assayed under standard condition (see
Material and Methods) and activities were extrapolated to saturating substrate concentrations
to obtain Vmax values (see text for details). Note that for PFK and PK the control rates are
given, see Materials and Methods for assay conditions. The error bars represent SEM, where the
number of measurements in different extracts (n) is displayed for each enzyme. The subscript
fwd and rev, refer to the forward and reverse rates respectively.
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GLC′[t] = vGLCtr− vHK (19)
G6P′[t] = vHK− vPGI (20)
F6P′[t] = vPGI− vPFK (21)
F16BP′[t] = vPFK− vALD (22)
DHAP′[t] = vALD− vTPI− vG3PDH (23)
G3P′[t] = vG3PDH− vGLYtr (24)
GAP′[t] = vALD+ vTPI− vGAPDH (25)
B13PG′[t] = vGAPDH− vPGK (26)
3PG′[t] = vPGK− vPGM (27)
2PG′[t] = vPGM− vENO (28)
PEP′[t] = vENO− vPK (29)
PYR′[t] = vPK− vLDH− vPYRtr (30)
LAC′[t] = vLDH− vLACtr (31)
ADP′[t] = vHK+ vPFK− vPGK− vPK+ vATPase (32)
NAD′[t] = vLDH− vGAPDH+ vG3PDH (33)
The model variables (metabolites), are defined in terms of fmoles per trophozoite, and time is
measured in minutes. Metabolites in the model rate equations are divided by their compartment
volume (fL) and the dissociation constants (K values) are given in M. Vmax values in the model
are given in M/min and are multiplied by the compartment volume, which leads to the rate units
of fmoles/min per trophozoite, which can be converted to the experimental rates measured in
µmoles/min/mg protein, using a cytosolic volume factor of 4.67 µL/mg protein and a trophozoite
volume of 28 fL (see Materials and Methods).
For steady state analyses the ODEs were set to zero and solved for metabolite amounts, assuming
fixed external concentrations of GLC, LAC, GLY and PYR of respectively 5, 2, 0.15, and 0.2 mM
and a total concentration for both the adenosine moiety (ATP + ADP) and the nicotinamide
adenosine moiety (NADH + NAD+) of 3 mM. The values for external metabolites are based
on plasma concentrations of healthy people and patients with low parasitaemia, (GLC [82, 83],
lactate [84, 85], pyruvate [85], glycerol [60, 86]) and we assumed that these concentrations are
similar to what Plasmodium experiences inside the RBC, based on the increased permeability
of the parasitised erythrocytes to a variety of solutes [87]. These external conditions reflect the
conditions in the validation experiments after 30’ incubation. For estimation of the moieties we
used the following references, adenosine moiety [73, 79, 81], and nicotinamide adenosine moiety
[81].
To simulate GLC conversion incubations made with intact trophozoites a second model was
constructed for which the set of ODEs was extended with four additional equations for the ex-
tracellular metabolites GLC, LAC, PYR and GLY. The ODEs for these extracellular metabolites
are equal to the rates of the respective transporters, scaled by the extracellular volume.
The complete model descriptions are given in Supplementary Material, and the models can be
simulated and downloaded in SBML format from the JWS Online Model repository:
(http://jjj.bio.vu.nl/models/penkler1 and /penkler2).
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4.4 Model validation
Two kinetic models were constructed to simulate the experimental conditions: the first with
external metabolite concentrations kept constant at the initial concentrations (i.e. to simulate
an open system reaching a steady state, penkler1 model), and a second model with the external
metabolites as free variables (i.e. simulating a closed system, penkler2 model). Both models are
available for simulation on the JWS Online website.
As an initial validation we compared model predictions for substrate consumption and product
formation rates with experimental values determined for incubations of intact trophozoites with
GLC, (Fig. 16). In addition to LAC, also GLY and PYR were produced by the trophozoites
and to be sure that these products were derived from the supplied GLC we used 14C-GLC
and obtained a full recovery of label in the measured products. The penkler2 model gives an
accurate prediction for substrate consumption and product formation rates, if an initial start-up
time of 10 minutes is assumed before the cells reach their maximal rates. Such a slow response
of the cells might reflect a de-energised state as they were washed before the incubation with
a buffer without GLC. For the model we chose initial concentrations for all metabolites as 0.1
mM, except for external GLC which was set to 5 mM and other external metabolites were set
to zero. Conserved moieties ATP + ADP, and NAD+ + NADH were set to 3 mM with initial
ratios of 1. The model simulations shown in Fig. 16 were largely independent of the initial
conditions of the intracellular metabolites, as long as the initial concentrations were not chosen
too low. With strongly de-energized initial conditions (i.e. low concentrations of intermediates
and ATP), model simulations show that glycolysis cannot start-up because it lacks ATP for the
HK and PFK reactions.
Additional incubations were made with unlabelled GLC and consumption rates for GLC and
production rates of LAC, PYR and GLY were determined (see Table 14). In these incubations
we also measured intermediate concentrations for G6P, F6P and F16BP after 30 min incubation,
assuming that the system has reached a steady state by then (see Table 14). For steady state
analysis of the penkler1 model the ODEs were set to zero with fixed concentrations for external
metabolites (see Section 4.3). A stable steady state could be calculated for these conditions and
fluxes and metabolite concentrations are presented together with the experimentally determined
values in Table 14. For the metabolites that could be detected experimentally (G6P, F6P
and F16BP) a good agreement between experimental measurement and model prediction was
obtained. Both DHAP and GAP could not be detected in our assay, which is in agreement with
the model prediction for GAP (0.05 mM), which would be below the detection limit (< 0.1 mM)
but is not in agreement with the 1.1 mM prediction of DHAP which should have been detected
in the assay.
With these comparisons of model simulations and experimental data we test whether the model
can predict the steady state substrate consumption and product formation rates and some of the
steady state intermediate concentrations in intact trophozoites on the basis of the kinetics that
were measured for the isolated enzymes. The model construction data set consists of initial rate
kinetics for each of the enzymes, which is very different from the steady state characteristics of
the complete pathway in the intact parasite, which were used as the validation data set. The
good agreement between model prediction and experimental validation is quite remarkable given
the high dimensionality of the system and the large number of kinetic parameters of the model.
One aspect that automatically follows from the steady state analysis of the mathematical model
and which has not been fully appreciated in the literature is the tight coupling of GLY and PYR
production. A role in redox metabolism for a G3P-shuttle has been suggested to be important
at low oxygen levels [11]. Such a shuttle effectively transfers reducing equivalents from NADH to
the electron transport chain via a cytosolic production and subsequent mitochondrial oxidation
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of G3P. However this shuttle does not produce glycerol, and it was not clear how P. falciparum
can produce glycerol and maintain a redox neutral metabolism. In our trophozoite incubations
we found a close coupling between PYR and GLY production in a 1:1 ratio, which was predicted
by the model and leads to a redox neutral metabolism (see also Fig. 1).
We fully realise that we have tested relatively few of the characteristics of the model and that this
certainly does not constitute a full model validation. We are currently preparing a manuscript
with further model validation (inhibitor titration of key enzyme) and analyses (sensitivity and
metabolic control analysis).
Table 14: Steady state concentrations and fluxes. The steady state metabolite concentrations
and fluxes as predicted by the model of P. falciparum glycolysis are compared to the experimen-
tally measured values. Metabolites marked with - were not assayed, metabolites marked with
n.d. were below the detection limit (< 0.1 mM).
Metabolite Model Experiment
(mM) (mM)
GLC 1.0 -
G6P 0.97 0.78 ± 0.06
F6P 0.30 0.15 ± 0.01
F16BP 1.4 0.8 ± 0.1
DHAP 1.3 n.d.
G3P 0.56 -
GAP 0.055 n.d.
B13PG 0.001 -
3PG 0.58 -
2PG 0.056 -
PEP 0.061 -
PYR 1.1 -
LAC 2.9 -
ATP 2.5 -
ADP 0.51 -
NADH 0.06 -
NAD+ 2.9 -
Flux Model Experiment
( µmolesmin·mg protein) (
µmoles
min·mg protein)
JGLCtr 0.049 0.055 ± 0.004
JLACtr 0.091 0.11 ± 0.01
JGLYtr 0.004 0.005 ± 0.001
JPYRtr 0.004 0.004 ± 0.001
5 General Discussion
Mathematical models are essential tools for the integration of interactions between network com-
ponents. Such interactions, which can be simple substrate/product links or feedback loops in
metabolism, must be taken into account to understand the functional behaviour of these net-
works [88]. Dependent on the network and on the specific research question, different modelling
approaches are used [89]. For large networks, phenomenological models are often used in top-
down approaches to describe data sets. These models do not have a strong mechanistic basis
but can include many components, and aim for complete descriptions of biological systems. In
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Figure 16: Model predictions of GLC consumption (A) and LAC (B), GLY (C) and PYR pro-
duction (D). Intact P. falciparum trophozoites (cytosolic volume/total volume = 0.106) were in-
cubated with 5 mM GLC (14C labeled) and external metabolite concentrations were determined
over a period of 90 minutes. Data points ( and  ) represent two independent experiments.
For the model simulation an initial 10 min startup time is assumed.
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contrast to the deductive top-down approach, bottom-up approaches are inductive and aim to
predict systems behaviour on the basis of the characteristics of their components. Such mod-
els are strong tools for testing of hypotheses, often with core models that capture an essential
characteristic. These hypotheses can subsequently be analysed in detailed models to test the
actual contribution of the suggested mechanism in models that capture our knowledge of the
system more completely. Such Silicon Cell type models should ideally be based on experimental
data for the isolated components and not fitted to systemic data sets [14]. If fitting on sys-
temic behaviour is necessary to obtain sufficient information then an independent validation is
required.
We have followed a bottom up approach for constructing a detailed kinetic model of P. falciparum
glycolysis. For the construction we made a kinetic characterisation for each of the glycolytic
enzymes and incorporated the resulting rate equations into a detailed kinetic model. In this
study, most of the kinetic data were fitted to convenient kinetic equations [18, 19, 90], e.g.
simple reversible Michaelis-Menten (uni-uni reactions) or random order (bi-bi reactions). It is
not expected that all of the bi-bi reactions follow random order binding, but the kinetic behaviour
is well described by these equations. It was not our aim to unravel the kinetic mechanism of
each of the glycolytic enzymes, but rather to capture the enzyme kinetics in a biochemically
sound rate equation that can be parameterised with a reasonable amount of enzyme kinetic
experiments [19, 90]. Thus, although we have not proven that the glycolytic enzymes follow
the exact mechanism that underlies our rate equation, we have shown that within physiological
ranges of substrates/products and effectors the enzyme rates can adequately be described with
our parameterised rate equations. In addition, the mechanistic equations have clearly defined
parameters that can be experimentally determined and provide a standard for the comparison
of parameters.
For our study we had to characterise the glycolytic enzymes using our own experimental data
since most of the enzymes that were characterised before were done so under optimal enzyme
conditions, which are not necessarily the same as the conditions under which the enzyme is
active in the cell. We tried to mimic the cytosolic conditions in terms of temperature and
pH, and measured all enzymes in the same incubation mixture. Five reaction steps were not
characterised experimentally in this study: the conversion of glycerol 3-phosphate to GLY and
transport of GLY across the membrane; PYR and LAC transport across the membrane; and the
ATPase reaction. The GLY production reaction is currently unknown, while for GLY transport
an aquaporin has been suggested [60]. We tried and could not detect G3P phosphatase activity
or glycerol kinase activity in cell extracts of P. falciparum. PYR and LAC transport had
been characterised before [10] and we converted the published kinetic rate equation into a form
suitable for our model. ATP consuming reactions were grouped into a single reaction and we
chose a kinetic form that dynamically buffers the ATP/ADP ratio around 5. The model consists
of 88 parameters, of which 11 were taken from the literature and 2 (for the ATPase) were fitted
to the physiological ATP/ADP ratio, while all other parameters were experimentally measured
in this study. The transport reactions across the parasitic cell membrane were the most difficult
to characterise. This is a more general characteristic of transport reactions that do not lead to
a chemical conversion, since these reactions are often prone to strong product inhibition and
therefore require fast experimentation to acquire so-called “zero-trans kinetics”. Working with
cells that do not have a sturdy cell-wall adds an additional challenge in preventing lysis when
washing the cells to remove extracellular substrate. Obtaining sufficient P. falciparum biomass
and intact trophozoites, not contaminated with RBC proteins, provided further challenges for
extensive enzyme characterisation.
Rate equations that are parameterised in the way described above and more extensively in
[14, 91], i.e. based on experimental measurements of the isolated enzymes, are to a large extent
independent of the model in which they are used (although limited to the conditions for which
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they were determined, i.e. pH and temperature). As such these parameterised rate equations can
be used in other models, which is important in our hierarchical modelling approach as outlined
in the introduction. We plan to merge the validated P. falciparum model with a red blood
cell model without changing the model parameters when we do so. Despite the more general
applicability of models and kinetic rate equations, one must be cautious to directly compare
enzyme kinetic parameters, or to use kinetic parameters from the literature, even when they
were determined under similar conditions, since reported Km values might be dependent on the
enzyme kinetic mechanism, i.e. the rate equation used to estimate their values. Strictly speaking
a Km value is only defined for the (irreversible, product insensitive) Michaelis-Menten equation.
Since the constant is mostly used as a half-saturation constant, i.e. the substrate concentration
at which the enzyme shows half-maximal activity, these values can be compared when enzymes
show simple hyperbolic saturation curves, but for more complicated kinetic mechanisms, for
instance in case of substrate inhibition, it is important to give the rate equation explicitly such
that parameter values can be converted to other mechanisms.
To prevent any misinterpretation and to enhance reusability of experimental data, it would
be even better to distribute annotated data files for each of the enzyme characterisations. This
would allow a user to add complementary data to the data set and/or fit custom equations to the
data that might be more suitable for his/her project. For such reuse of (parts of) models, which
is essential in modular approaches, where validated models for different parts of metabolism
are linked to construct kinetic models of larger systems [92], it is important to use standard
description formats and to make data and models publicly available in annotated form.
For this study we have made all experimental data available in RightField annotated spread-
sheets [93] using the EuroSEEK platform ([20]) as developed in the FAIRDOM project (http://www.fair-
dom.org). This investigation (doi:10.15490/seek.1.investigation.56) currently has two studies:
“model construction” and “model validation”. The model construction study has for each of the
enzymes an experimental assay with the kinetic data, a SOP file with the experimental spec-
ifications, and a model file that imports the experimental data, specifies the parameterisation
methods and produces the manuscript figures (Fig. 17). The model validation study links to the
validation experiments and the complete model description file. The model files are available as
Mathematica notebooks and as SBML files. In addition, the models can be simulated on JWS
online [94], and links to experimental data are available for each of the individual processes via
the reaction plot functionality in the model schema. The model can be downloaded in SBML
format [95] and is annotated according to MIRIAM standards [96].
The approach we have followed for model construction and validation has been used before
for modelling glycolysis in other organisms (e.g. Trypanosoma brucei [15], yeast [16] and red
blood cells [4]) but these studies relied to a large extent on available data in the literature and
experimental data was not made available. In a more recent effort to construct a kinetic model
for yeast glycolysis, where the contribution of the different iso-enzymes were taken into account
[97], the kinetic data was uploaded to the SABIO-RK database [98], and workflows were used for
model construction [99]. However, a user cannot repeat the model construction process that the
authors have used. We aimed to make the model construction process completely transparent,
making all the experimental data and all the model files that were used for model construction
and validation public. The distribution of complete experimental data sets that were used in
modelling studies is very rare (for an exception see [39]).
In this first publication we focus on the construction and an initial validation of a detailed
kinetic model for glycolysis in the malaria parasite P. falciparum; we kinetically characterised
15 enzymes in the pathway, and built a model on the basis of the isolated in vitro kinetics
and tested the model in its prediction of steady state glycolytic flux and hexose phosphate
intermediates in the intact trophozoite stage of the parasite. In a follow up study we will report
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Figure 17: ISA Structure for the “Glucose metabolism in P. falciparum trophozoites” investiga-
tion in the EuroSEEK platform. The model construction and model validation studies and their
linked assays are shown. For each of the reaction steps in the model an experimental data file,
SOP document and model file are available. RightField [93] annotated Excel spreadsheets are
used for the data files and the “penkler1”and “penkler2” model files are available as MIRIAM
annotated [96] SBML files [95].
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on additional validation experiments and model analyses.
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7 Materials and Methods
7.1 Culturing and synchronisation of P. falciparum
Packed human erythrocytes (A+, obtained from the Western Province Blood Bank, South
Africa) were suspended (3-4 % v/v) in RPMI 1640 culture medium supplemented with Albumax
II (0.5% w/v), 22 mM GLC, 25 mM HEPES, 3 mM hypoxanthine, 25 mM sodium bicarbonate
and 50 µg/mL gentamycin sulphate, infected with P. falciparum D10 and incubated with 3%
oxygen, 4% carbon dioxide and 93% nitrogen at 37 ◦C as described elsewhere [100, 101].
Parasite cultures were synchronised by suspending pelleted infected erythrocytes (750 × g, 3
min), in a 5% w/v sorbitol solution and incubating the suspension at 37◦C for 5 min as described
by Hoppe et al. [102]. Sorbitol treatment leaves the erythrocytes intact, but inactivates all the
parasites except the ones in the ring stage.
7.2 Trophozoite Isolation and Lysate Preparation
Approximately 32 hours after invasion, trophozoites were isolated from infected erythrocytes
using a saponin lysis protocol [73]. Saponin permeabilises the erythrocyte and parasitophorous
vacuolar membranes by interacting with cholesterol found in these membranes [103, 104], but
leaves the parasite plasma membrane intact [73, 105], which was verified in trypan blue exclusion
tests [105].
After washing isolated trophozoites twice in assay buffer, lysates were prepared by three freeze
(liquid nitrogen) - thaw (room temperature) cycles, with a 30 second sonication step in be-
tween cycles. After centrifugation (10 000 ×g, 10 min), the supernatant was used for kinetic
determinations. Lysates were prepared fresh before enzyme kinetic assays and kept on ice.
7.3 Enzyme Characterisation
Specific activity of the glycolytic enzymes were measured in NAD(P)H/NAD(P)+ linked enzyme
assays that were adapted from Teusink et al. [16] and measured at 340 nm in 96-well plates
(Flat Bottom microplate, Greiner Bio-One, Kremsmünster, Austria) on a spectrophotometer
(VarioSkan microplate reader, Thermo Electron Corporation, Waltham, Massachusetts, USA).
The same buffer, (20 mM HEPES, 20 mM MgCl, 10 mM KCl and 20 mM NaCl), with an ionic
strength close to 0.1 M, was used for all assays, with a pH set to 7.17, matching the cytosolic
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pH of P. falciparum D10 [74]. All of the linking enzymes were used at a non-limiting, final con-
centration of 5 U/mL. All reagents and enzymes were obtained from Sigma-Aldrich, St. Louis,
Missouri, USA.
For each enzyme the complete experimental data set was fitted with a single rate equation. To
compensate for differences in enzyme expression levels in different cell lysates, enzyme activities
were normalised to their respective Vmax values and combined into a single data array for fit-
ting. For fitting we used the NonlinearModelFit function of Wolfram Mathematica®, Wolfram
Research, Inc. Champaign, Illinois, USA. All data sets and mathematical models of the fitted
rate equations for the respective enzymes have been made available in the SEEK platform. Note
that for PFK and PK, for which a Vmax value cannot be estimated via extrapolation due to
substrate inhibition, the activities were normalised to standardised substrate concentrations (see
the respective enzyme assay methods). The activity measured under these standard conditions
was scaled to a Vmax value after fitting the combined normalised data set.
Hexokinase (HK) was characterised in the forward direction in terms of GLC (0 -10 mM) and
ATP (0 - 10 mM) and inhibition by ADP (0 - 20 mM) by linking the production of G6P to
the reduction of NADP+ (0.8 mM) via G6PDH. Product inhibition by G6P (0 - 30 mM) was
characterised by linking the production of ADP to the oxidation of NADH (0.8 mM) via LDH
and PK in the presence of PEP (2 mM).
Phosphoglucoisomerase (PGI) activity was measured via the conversion of G6P (0 - 35 mM) to
F6P, which was linked to the oxidation of NADH (0.8 mM) via αGlyPDH, ALD, TPI, PFK in
the presence of ATP (2 mM). The reverse isomerisation of F6P (0 - 5 mM) to G6P was linked
to reduction of NADP+ (0.8 mM) via G6PDH.
For phosphofructokinase (PFK) activity, the phosphorylation of F6P (0 - 30 mM) by ATP
(0 - 5 mM) as well as inhibition by ADP (0 - 5 mM) was linked to the oxidation of NADH
(0.8 mM) via αGlyPDH, ALD, TPI. Product inhibition by F16BP (0 - 60 mM) was assayed
by linking the production of ADP to the oxidation of NADH (0.8 mM) via LDH, PK in the
presence of PEP (2 mM). Since PFK exhibited substrate inhibition, the enzyme rates could not
be normalised to maximal specific activity at saturating substrate concentrations. A control
rate was determined at 1.25 mM ATP and 1 mM F6P.
Aldolase (ALD) activity was characterised in terms of F16BP saturation (0 - 0.8 mM) by linking
the production of DHAP to the oxidation of NADH (0.8 mM) via αGlyPDH in the presence of
excess TPI.
Triosephosphate isomerase (TPI) activity was assayed in both directions via αGlyPDH or
GAPDH in the presence of NADH (0.8 mM) and GAP (0 - 1.2 mM ) or NAD+ (0.8 mM),
KH2PO4 (10 mM) and DHAP (0 - 15 mM ) respectively.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was assayed with varying substrate con-
centrations NAD+ (0 - 2.5 mM), GAP (0 - 5 mM) and KH2PO4 (10 mM) and in the reverse
direction with NADH (0 - 0.8 mM) and 3PG (0 - 2.5 mM). Since B13PG is not commercially
available, 3-phosphoglycerate was varied in a PGK linked assay and equilibrium concentrations
for B13PG were calculated by solving the following equation for x: (3PG−x)(ATP−x)
x2 = KeqPGK ,
with 3PG and ATP the initial concentrations in the incubation.
Glycerol 3-phosphate dehydrogenase (G3PDH) activity was assayed by varying substrate con-
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centrations NADH (0 - 0.36 mM) and DHAP (0 - 5.55 mM). Product inhibition by G3P (0 -
16.7 mM) in the presence of NADH (0.36 mM) and DHAP (0.22 mM) was measured as well as
product inhibition by NAD+ (0 - 8.4 mM) with DHAP (5.55 mM) and NADH (0.22 mM).
Phosphoglycerate kinase (PGK) activity was assayed in the reverse direction by linking the
production of B13PG from ATP (0 - 5 mM) and 3PG (0 - 10 mM) in the presence of ADP (0 -
6 mM) to the oxidation of NADH (0.8 mM) via GAPDH.
Phosphoglycerate mutase (PGM) activity was monitored via the conversion of 3PG (0 - 10
mM) to 2PG, which was linked to the oxidation of NADH (0.8 mM) via LDH, PK, ATP (2 mM)
and ENO. The reverse reaction (2PG 0 - 20 mM ) was linked to NADH (0.8 mM) oxidation by
GAPDH via PGK and ATP (2 mM).
Enolase (ENO) activity was measured via the conversion of 2PG (0 - 10 mM ) to PEP, which
was linked to NADH oxidation by LDH via PK and ADP (2mM) and in reverse direction via
conversion of PEP (0 - 12 mM) to 2PG, which was linked to NADH (0.8 mM) oxidation by
GAPDH via PGM, PGK and ATP (2 mM).
Pyruvate kinase (PK) was measured via the conversion of ADP (0 - 5 mM) and PEP (0 -
5 mM) in the presence of ATP (0 - 5 mM) by linking the reaction to NADH oxidation via LDH
and in the presence of PYR (0 - 100 mM) by linking the production of ATP to the reduction of
NADP+ (0.8 mM) via G6PDH, HK and GLC (10 mM). Since PK exhibited substrate inhibition,
the enzyme rates could not be normalised to maximal specific activity at saturating substrate
concentrations. A control rate was determined at 1.25 mM PEP and 0.625 mM ADP.
Lactate dehydrogenase (LDH) was characterised via oxidation of NADH (0 - 0.8 mM) in the
presence of pyruvate (0 - 2.5 mM) and in the reverse direction via reduction of NAD+ ( 0 - 2
mM) in the presence of lactate (0 - 80 mM).
7.4 GLC transport characterisation
GLC uptake rate was measured using a modification of the method by Walsh et al. [106, 107].
Isolated trophozoites were washed and suspended in GLC free, modified Ringer buffer (25 mM
HEPES, 1 mM MgCl2, 10 mM KCl, 120 mM NaCl, pH 7.1) similar to that described by Wünsch
et al. [74] and stored on ice. A small aliquot of this suspension was incubated at 37◦C in a
petri dish and mixed with an equal volume of radiolabelled D-[1-14C] GLC (1 - 20 mM, specific
radioactivity 700 to 10 Bq nmol−1, pre-incubated at 37◦C) and incubated for 2 s. Uptake was
halted by quenching with 10 mL of quench buffer (500 mM GLC, 25 mM HEPES, 1 mM MgCl2,
10 mM KCl, 120 mM NaCl, pH 7.1, incubated at -5◦C on a salt-ice mixture). The trophozoites
were immediately transferred to a 0.45 µm filter (HVLP, Millipore), covered with a thin layer
of filter aid Celite 545, Sigma-Aldrich, to prevent clogging) and washed with 10 mL of ice-cold
quenching solution, after which the filters were transferred to scintillation vials containing 5 mL
scintillation fluid (Flo-Scint III, PerkinElmer, Waltham, Massachusetts, USA). In the negative
control experiment the quench fluid was added before the labelled GLC.
In addition, a simple programmable quench-flow device was utilised (see Supplementary Material
for a detailed description of the device design, construction and calibration) for GLC uptake
experiments with less than 2 s incubation times. For these experiments sample and buffer
preparations were identical to the 2 s incubation experiments but now GLC and trophozoites
were loaded into separate, temperature (37◦C) controlled sample chambers of the quench-flow,
and injected through a mixing chamber into a collection vial and at the pre-programmed time
the reaction was stopped by injection of the quenching solution.
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7.5 Flux and Internal Metabolite Experiments
For the glycolytic flux and metabolite determination experiments, trophozoites were isolated,
washed twice and suspended in incubation a modified Ringer buffer (5 or 10 mM GLC, 50
mM HEPES, 1 mM MgCl2, 10 mM KCL, 120 mM NaCl, pH 7.1) similar to that described
by Wünsch et al.[74]. In this buffer the parasites were able to exclude 0.04% v/v trypan blue.
Immediately after suspension, two aliquots were taken for cell counting (Improved Neubauer
Haemocytometer) and total protein determinations (method of Bradford et al. [108]). An
intracellular trophozoite volume of 4.67 µL per mg protein was calculated on the basis of cell
counts, total protein determination, and a 28 µL volume per trophozoite [109].
External metabolites were determined in two ways i) enzymatically and ii) using a radiolabelled
HPLC method with 14C labelled GLC (uniformly labeled and used in a 1:80 ratio with unlabelled
glucose) as substrate. For both methods, time point samples of the incubation were centrifuged
(5000 × g, 1 min) and the supernatant i) retained for enzymatic determinations or ii) added
to acetonitrile (70% v/v final) for HPLC determination (see below). For the determination of
internal metabolites at specific time intervals, aliquots of the cell suspension were taken and
metabolism halted by the addition of 70% m/v perchloric acid (12% m/v final concentration).
Following 1 min sonication and centrifugation (10 min, 20 000xg, 4 °C), the supernatant was
retained for the enzymatic determination of the glycolytic metabolites. The supernatant was
neutralised with 10 M KOH. Samples were stored at -80°C until analysis.
7.6 Enzymatic GLC, Lactate, Pyruvate and Glycerol determinations
Extracellular D-GLC was assayed by linking it to NADP reduction via HK and G6PDH. Samples
and standards were incubated at room temperature in HEPES buffer (50 mM, pH 7.5) containing
HK (5 U/mL), ATP (0.2 mM), G6PDH (10 U/mL) and NADP+ (0.5 mM). After a 15 minute
incubation period the absorbance at 340 nm was measured. Extracellular L-lactate was assayed
by using an LDH and NAD+ linked assay. After a 20 min incubation period at room temperature
in HEPES buffer (50 mM, pH 7.5) containing LDH (10 U/mL), NAD+ (0.2 mM) and hydrazine
(16 µL/mL), samples and standards were measured at 340 nm. Hydrazine binds to pyruvate and
thus thermodynamically drives the unfavourable LDH reaction (reverse) to completion. Glycerol
was measured using the method developed by Eggstein and Kuhlmann [110]. Glycerol samples
and standards were incubated in assay buffer (150 mM HEPES (150 mM), MgSO4 (15 mM), pH
7.5) with glycerol kinase (8.4 U/ mL), PEP (1 mM), NADH (0. 4 mM), ATP (1 mM), pyruvate
kinase (3 U/mL) and lactate dehydrogenase (3.6 U/ mL) and the oxidation of NADH after 10
min was measured at 340 nm. Pyruvate samples and standards were incubated in HEPES buffer
(50 mM, pH 7.5) containing LDH (10 U/mL) and NADH (0.1 mM) and the absorbance after
10 minutes measured at 340 nm.
7.7 Enzymatic Determination of Metabolites
The intermediates of upper glycolysis (G6P, F6P, F16BP, DHAP and GAP) were all assayed
within a single sample (180 µL) by linking the metabolite assays to the reduction of NADP+
via G6PDH or oxidation of NADH via α-glycerolPDH. G6P was determined by adding G6PDH
(1U/mL final) and NADP+ (5 mM final). Total change in absorbance at 340 nm was determined
upon completion of the reaction. A spike of G6P (20 µM) was added and change in absorbance
determined once the reaction was complete. To the same sample, PGI (1U/mL final) was added
for assaying F6P and again the total change in absorbance determined. After completion, a 20
µM F6P spike was added to the mixture. In a similar stepwise (sample/spike) manner, DHAP,
GAP and FBP were determined via NADH (0.8 mM final) and α-glycerolPDH (1U/mL final,
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TPI (1U/mL) and aldolase (1U/mL) respectively. Under these experimental conditions there
is a linear dependency between absorbance (340 nm) and metabolite (G6P, F6P and F16BP)
concentration (2 - 200 µM). The change in absorbance for the 20 µM intermediate spike was
thus used as an internal standard to determine the concentration of each intermediate within the
sample. The intermediates of lower glycolysis could not be determined due to high concentrations
of lactate and pyruvate in the samples. This prevented the linked determination of PEP and the
phosphoglycerates via LDH and NADH. Trophozoite counts and the assumption of a trophozoite
cytosolic volume of 28 fL [109] were used to calculate the intracellular concentration of each
metabolites.
7.8 GLC, Lactate, Pyruvate and Glycerol HPLC Determinations
The method of Antonio et al. [111] was employed to determine the concentrations of the radi-
olabelled extracellular GLC, lactate, pyruvate and glycerol. Antonio et al. [111] did not detect
glycerol as it ionises poorly in an ESI (electro-spray ionisation) source. GLC, lactate, pyruvate
and glycerol eluted at 13.4, 6.5, 10.1 and 10.4 min respectively. We confirmed that the eluent
at 10.4 min was glycerol using enzyme determination assays. Briefly, separation occurred on
a ZIC®-HILIC column (150×7.5 mm, 5 µm, 200 Å, SeQuant™, Merck, Darmstadt, Germany)
fitted with a guard column (20×2.1mm, 5 µm, SeQuant™, Merck, Darmstadt, Germany) on a
HPLC system. The system consists of a SpectraSYSTEM P4000 pump (Thermo Separation™
products, San Jose, CA, USA), a SpectraSYSTEM AS3000 autosampler (Thermo Separation™
products, San Jose, CA, USA) and a Flo-One liquid scintillation spectrophotometer (Radiomatic,
Tampa, FL, USA). A flow rate of 1.0 mL/min and an injection volume of 100 µL were used.
Separation occurred at room temperature (25°C). Mobile phase A consisted of acetonitrile (0.1%
m/v formic acid) and mobile phase B of 5 mM ammonium acetate, pH 4 (0.1% m/v formic acid).
The method was slightly modified by pumping 90% v/v A through the system for 1 min, prior
to the initiation of the gradient elution profile. The analogue intensity (V) data were integrated
and analysed with Mathematica®.
7.9 Computational Modelling
All computational analyses were made with Wolfram Mathematica® version 10. Parameter esti-
mations for the individual rate equations were performed using the NonlinearModelFit function
with either the default method or the NMinimize method, as is indicated in the Mathematica
notebooks for the individual reaction steps available on OpenSEEK. The kinetic models were
formulated as sets of ordinary differential equations (ODEs) on the basis of known reaction stoi-
chiometry of the Embden-Meyerhof-Parnas pathway. The ODEs were solved using the NDSolve
function. Steady state was calculated using the FindRoot function. The numerical simulations
were confirmed in Copasi [112]. The models are available as Mathematica notebooks and SBML
files, and can be simulated in a browser via JWS Online [94].
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